Page last updated: 2024-08-16

ribavirin and Liver Neoplasms

ribavirin has been researched along with Liver Neoplasms in 274 studies

Research

Studies (274)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (2.55)	18.2507
2000's	79 (28.83)	29.6817
2010's	162 (59.12)	24.3611
2020's	26 (9.49)	2.80

Authors

Authors	Studies
Abdel-Bary, HM; El Sayed, IET; Ghanm, SE; Othman Saad, W; Saad, BF; Shebl, NA	1
Baré, PC; Cairo, FM; Cocco, PA; Massenzio, NE; Picchio, GR; Villamil, FG	1
Bian, E; Hao, L; Huang, X; Tian, Y; Wu, Y; Yang, R; Yang, W; Yang, Y; Zhang, B; Zhang, Q	1
Jang, JY; Jun, DW; Jung, YK; Kim, MY; Kim, SG; Kwon, OS; Lee, JW; Lee, SH; Park, JY; Yoo, HW	1
Calvisi, DF; Feo, CF; Feo, F; Pascale, RM; Simile, MM	1
Balbi, E; Cardoso, SW; Carius, L; Grinsztejn, B; Halpern, M; Pacheco, L; Perazzo, H; Pinto, L; Roma, J; Veloso, VG	1
Amendola Pires, M; Barbosa, ENP; Brandão Mello, CE; Campos, LB; de Almeida, NAA; de Barros, JJF; de Paula, VS; de Santana, CG; Horta, MAP	1
Abdel-Rahman, YO; Abdel-Razik, W; Dabbous, HM; Elakel, W; Elmakhzangy, H; Elshafaey, A; Esmat, G; Ismail, SA; Omar, H; Saeed, R; Salama, R; Waked, I; Ziada, DH	1
Adenugba, A; Bitterer, F; Geissler, EK; Kupke, P; Schemmerer, M; Schlitt, HJ; Wenzel, JJ; Werner, JM	1
Hussain, N; Iqbal, M; Mahnoor, M; Maqsood, Q; Sumrin, A; Wajid, A; Younas, S	1
Coppola, N; Devan, P; Mohan, BP; Neo, JE; Preda, CM; Tam, YCS; Tiong, KLA; Wijarnpreecha, K; Wong, YJ	1
Dong, G; Jiang, J; Li, J; Li, X; Long, S; Su, M; Wei, Y; Zhou, Y	1
Anderson, M; Banda, CC; Bhebhe, L; Blackard, JT; Choga, WT; Essex, M; Gaseitsiwe, S; Mbangiwa, T; Melamu, P; Moyo, S; Musonda, RM; Phinius, BB; Shaver, ZM; Souda, S; Zumbika, E	1
Chang, PH; Chen, YT; Chien, CH; Chien, RN; Hu, CC; Hua, MC; Lin, CL; Lin, ST; Weng, CH	1
Aguilar, H; Asatryan, A; Bondin, M; Cacoub, P; Carvalho, A; Castro, RE; Charafeddine, M; Cohen, DE; Dieterich, D; Felizarta, F; Hu, YB; Khan, N; Marinho, RT; Poordad, F; Siddique, A	1
Chung, WJ; Jang, ES; Jeong, SH; Kim, IH; Kim, KA; Kim, YS; Lee, BS; Lee, YJ	1
Cheng, X; Du, LY; Liao, J; Ma, YJ; Tang, H; Xie, WW; Yan, LB	1
Abou-Samra, AB; Butt, AA; Nasir, B; Rasool, S; Rubi, G; Tayyab, GUN	1
Ahmed, H; Elsadek, HM; Elsayed, IA; Gendia, MA; Gouda, TM; Lbrahim, NF; Magdy, MM; Sadek, AMEM; Shafeik, H; Shendi, AM; Yousif, MM; Zahran, MH; Zaki, AM	1
Attia, A; Baudoin, M; Boyer, S; Kouanfack, C; Lacombe, K; Lemoine, M; Moh, R; Nishimwe, ML; Rouveau, N; Seydi, M; Sylla, B; Woode, ME	1
Barrett, BK; Chan, J; Feld, JJ; Hamadeh, A; Kim, JJ; Wong, WWL	1
Chen, SC; Cheng, TS; Chuang, WL; Dai, CY; Hsieh, PH; Huang, CF; Huang, CI; Huang, JF; Liang, PC; Lin, ZY; Yeh, ML; Yu, ML	1
Al-Tawashi, AS; Alaa, AM; Awwad, MA; El-Derany, MO; Eltobgy, MM; Gharib, MM; Kasem, MH; Mostafa, AM; Moubarak, AS; Omar, HM; Saafan, HA	1
Abdelbaser, ES; Elsadek, HM; Emara, MH; Farag, AA; Soliman, HH	1
Chifulescu, AE; Diculescu, M; Gheorghe, LS; Iliescu, L; Istratescu, D; Manuc, M; Pop, CS; Preda, CM; Tieranu, C; Voiosu, T	1
Aghemo, A; Boccaccio, V; Bruno, S; Cabibbo, G; Calvaruso, V; Colombo, M; Craxì, A; Crosignani, A; Di Marco, V; Giacomelli, L; Iavarone, M; Maisonneuve, P; Roffi, L; Rossi, S	1
Carmona-Soria, I; Caunedo-Alvarez, A; Cordero-Ruiz, P; Flores-Cucho, A; Quezada-Pacheco, RH; Rodríguez-Téllez, M; Romero-Gómez, M; Vilches-Arenas, Á	1
Fujikawa, T; Iwabuchi, S; Matsui, K; Nagata, M; Nakano, M; Nakazaki, H; Shimizu, H; Takatsuka, K; Tanemura, H; Watanabe, T	1
Kaabi, SA; Singh, R; Soofi, ME; Thandassery, RB; Tharian, B	1
Lin, HC; Su, CW; Yang, YY	1
Attarian, S; Haigentz, M; Kaubisch, A; Sharma, J; Zonszein, J	1
Aikata, H; Chayama, K; Daijo, K; Fujino, H; Hatooka, M; Hayes, CN; Hiramatsu, A; Honda, F; Imamura, M; Kan, H; Kawakami, Y; Kawaoka, T; Kobayashi, T; Masaki, K; Miki, D; Morio, K; Morio, R; Nagaoki, Y; Nakahara, T; Nakamura, Y; Ochi, H; Ono, A; Teraoka, Y; Tsuge, M	1
Bian, DD; Chen, Y; Duan, C; Duan, ZP; Jiang, YY; Liu, M; Liu, S; Wang, T; Wang, Z; Zhang, JY; Zheng, SJ; Zhou, HY	1
Rostkowska, K; Simon, K; Szymanek-Pasternak, A	1
Caraceni, P; Carrai, P; Donato, MF; Fagiuoli, S; Filì, D; Gianstefani, A; Martini, S; Mazzarelli, C; Melazzini, M; Montilla, S; Pani, L; Petraglia, S; Rendina, M; Russo, P; Trotta, MP; Visco-Comandini, U	1
Hayashi, Y; Imoto, S; Kato, A; Kim, CW; Kim, KI; Kim, SK; Kim, SR; Kobayashi, M; Kudo, M; Morimoto, E; Ohtani, A; Saijo, Y; Seo, K; Yano, Y	1
Hu, Y; Song, M; Tan, J; Ye, J; Zhou, M	1
Al-Zoairy, R; Beinhardt, S; Datz, C; Ferenci, P; Graziadei, I; Gschwantler, M; Hofer, H; Kozbial, K; Laferl, H; Maieron, A; Moser, S; Schwarzer, R; Stättermayer, AF; Stauber, R; Steindl-Munda, P; Strasser, M; Trauner, M; Zoller, H	1
Chang, KC; Chen, CH; Hu, TH; Hung, CH; Kuo, FY; Lin, JT; Lin, MT; Lu, SN; Tsai, MC; Tseng, PL; Wang, JH; Wu, CK; Yen, YH	1
Hamano, G; Ito, T; Kawada, N; Kubo, S; Takemura, S; Tamori, A; Tanaka, S	1
Ahmed, B; Ghaffar, A; Jalal, F; Kamran, SK; Kiran, S; Munir, B; Oranab, S; Shehzadi, S; Zahoor, MK	1
Al-Zoairy, R; Beinhardt, S; Ferenci, P; Graziadei, I; Hofer, H; Kozbial, K; Maieron, A; Rasoul-Rockenschaub, S; Stättermayer, AF; Stauber, R; Strasser, M; Trauner, M; Zoller, H	1
Chang, KC; Hu, TH; Lin, MT; Tsai, MC; Tseng, PL; Wu, CK; Ye, YH	1
Bittermann, T; Weinberg, E	1
Bergmann, OM; Björnsson, ES; Fridriksdottir, RH; Gottfredsson, M; Gudnason, T; Hansdottir, I; Heimisdottir, M; Hellard, M; Johannsson, B; Löve, A; Löve, TJ; Olafsson, S; Runarsdottir, V; Sigurdardottir, B; Tyrfingsson, T	1
Kanda, T; Matsuoka, S; Moriyama, M	1
Masumoto, A; Miyazaki, M; Motomura, K; Tanaka, K; Yada, M	1
Aghemo, A; Aglitti, A; Andreone, P; Boccaccio, V; Bollani, S; Brunetto, MR; Bruno, S; Calvaruso, V; Ciancio, A; Coco, B; Conti, F; Degasperi, E; Di Leo, A; Di Marco, V; Giorgini, A; Lampertico, P; Lleo, A; Maisonneuve, P; Marzi, L; Persico, M; Rendina, M; Troshina, G; Villa, E; Zuin, M	1
Abbas, B; Asem, N; Elsharkawy, A; Esmat, G; Gomaa, A; Hassany, M; Maged, A; Mehrez, M; Mostafa, Z; Soliman, M	1
Zhang, DZ; Zhang, QY; Zhu, F	1
Berak, H; Białkowska, J; Bolewska, B; Fleischer-Stępniewska, K; Flisiak, R; Garlicki, A; Janczewska, E; Karpińska, E; Karwowska, K; Nazzal, K; Piekarska, A; Simon, K; Tomasiewicz, K; Tronina, O; Tuchendler, E; Zarębska-Michaluk, D; Łucejko, M	1
But, DYK; Chan, CW; Chan, HLY; Chan, JMC; Cheung, WI; Chow, WH; Fan, TTT; Fung, JYY; Hui, AJ; Hui, YT; Kung, KN; Lai, KB; Lai, LSW; Lai, MS; Lam, BCY; Lam, JTW; Lam, K; Lao, WC; Lau, JYL; Leung, NWY; Li, MKK; Liu, K; Liu, SD; Loo, CK; Lui, TKL; Luk, WF; Ma, YK; Mak, WY; Ng, ACY; Shan, EHS; Tong, RKN; Tsang, OTY; Tsang, SWC; Wong, GLH; Wong, VWS; Yuen, MF	1
Chang, Y; Cho, EJ; Cho, H; Cho, YY; Hwang, SG; Kim, HY; Kim, YJ; Lee, DH; Lee, JH; Lee, JM; Lee, YB; Nam, JY; Yoon, JH; Yu, SJ	1
Asaoka, Y; Enooku, K; Fujiwara, N; Koike, K; Minami, T; Nakagawa, H; Nakagomi, R; Nishibatake Kinoshita, M; Sato, M; Shiina, S; Tateishi, R; Uchino, K; Wake, T	1
Angelidakis, G; Blechacz, B; Economides, MP; Granwehr, BP; Hosry, J; Jiang, Y; Kaseb, A; Kyvernitakis, A; Mahale, P; Miller, E; Naing, A; Raad, II; Samaniego, F; Torres, HA	1
Chang, KC; Chen, CH; Hu, TH; Hung, CH; Kee, KM; Lin, MT; Lu, SN; Sou, FM; Tsai, MC; Wang, JH; Wu, CK; Yen, YH	1
Chen, WT; Chen, YC; Hsieh, YC; Huang, CH; Jeng, WJ; Lin, CC; Lin, CY; Lin, SM; Sheen, IS; Teng, W	1
Dohi, T; Jain, A; Kadry, Z; Krok, KL; Miller, D; Riley, TR; Schreibman, I; Sharma, R	1
Akarca, US; Akdogan, M; Akhan, S; Aladag, M; Ataseven, H; Cakaloglu, Y; Cavus, B; Demir, M; Erol, C; Ersoz, G; Gunduz, F; Gunsar, F; Idilman, R; Iliaz, R; Karasu, Z; Kaymakoglu, S; Kiyici, M; Koklu, H; Koksal, AS; Koksal, İ; Ozgenel, M; Sahin, M; Tabak, F; Turan, İ	1
Cho, M; Han, SY; Heo, J; Kim, DU; Kim, GH; Kim, HH; Park, SG; Park, YJ; Pyeon, SI; Song, GA; Woo, HY	1
Angelico, M; Antonucci, F; Armenia, D; Bellocchi, MC; Carioti, L; Ceccherini-Silberstein, F; Cento, V; Ciancio Manuelli, M; De Leonardis, F; Lenci, I; Manzia, TM; Milana, M; Perno, CF; Sforza, D; Sorbo, MC; Tisone, G	1
Baicus, C; Constantinescu, I; Diculescu, M; Dumitru, R; Gavrila, D; Istratescu, D; Manuc, M; Manuc, T; Oproiu, A; Preda, CM; Sandra, I; Tieranu, C; Vasilescu, C; Voiosu, T	1
Kanda, T; Kaneko, T; Komoriya, T; Kuroda, K; Matsumoto, N; Matsuoka, S; Moriyama, M; Nakajima, N; Nirei, K; Ogawa, M; Shibata, T; Takayama, T; Tamura, A; Yamamoto, T; Yamazaki, M	1
Abd-Rabou, AA; Bharali, DJ; Mousa, SA	1
Aldámiz-Echevarría, T; Bellón, JM; Berenguer, J; Carrero, A; Díez, C; Fanciulli, C; Garcia-Broncano, P; Jiménez-Sousa, MA; Medrano, LM; Miralles, P; Pérez-Latorre, L; Resino, S	1
He, SF; Qi, ZT; Ren, H; Wang, W; Zhao, LJ	1
Jia, JD; Rakhda, MI; Wang, TI; Zhao, XY	1
Ariumi, Y; Hiramoto, A; Hiraoka, O; Ikeda, M; Kato, N; Mori, K; Wataya, Y	1
Chen, PJ; Chu, YT; Kuo, RN; Lai, MS; Liu, CJ; Shau, WY	1
Asahina, Y; Enomoto, N; Hosokawa, T; Itakura, J; Izumi, N; Kakinuma, S; Kurosaki, M; Muraoka, M; Nakagawa, M; Nakanishi, H; Nishimura, T; Suzuki, Y; Takahashi, Y; Tamaki, N; Tsuchiya, K; Ueda, K; Watanabe, M; Yasui, Y	1
Arakawa, Y; Higuchi, T; Matsumura, H; Moriyama, M; Nakamura, H; Nirei, K; Ogawa, M; Tanaka, N	1
Lo, GH	1
Hsu, YC; Wu, CY	1
Khokhar, N; Niazi, TK; Qureshi, MO	1
Genda, T; Hirano, K; Ichida, T; Iijima, K; Ishikawa, S; Kanemitsu, Y; Kikuchi, T; Narita, Y; Sato, S; Tsuzura, H; Wada, R	1
Liu, CJ	1
Mahale, P; Okhuysen, PC; Torres, HA	1
Fukui, H; Hagiwara, H; Hamasaki, T; Hayashi, E; Hayashi, N; Hijioka, T; Hiramatsu, N; Imai, Y; Inada, M; Inoue, A; Inui, Y; Ito, T; Kasahara, A; Katayama, K; Kato, M; Mita, E; Miyagi, T; Miyazaki, M; Oshita, M; Oze, T; Takehara, T; Tamura, S; Tatsumi, T; Yakushijin, T; Yamada, A; Yoshida, Y; Yoshihara, H	1
Dekio, F; Malik, S; Wen, JW	1
Chen, SC; Chuang, WL; Dai, CY; Hsieh, MH; Hsieh, MY; Huang, CF; Huang, JF; Lin, ZY; Tsai, PC; Wang, LY; Yang, HL; Yang, JF; Yeh, ML; Yu, ML	1
Gervain, J; Horváth, G; Hunyady, B; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I	1
Chayama, K; Imamura, M	2
Chapman, R; Costella, A; De Angelis, D; Griffiths, J; Harris, HE; Harris, RJ; Ramsay, M; Thomas, B	1
Sakamoto, N	1
Goto, H; Hayashi, K; Hirooka, Y; Honda, T; Ishigami, M; Ishikawa, T; Ishizu, Y; Itoh, A; Katano, Y; Kumada, T; Kuzuya, T; Masuda, H; Nakano, I; Toyoda, H; Urano, F; Yoshioka, K	1
Ahn, SH; Baatarkhuu, O; Han, KH; Jung, KS; Kim, BK; Kim, DY; Kim, SU; Moon, C; Park, JY	1
Afdhal, N; Arterburn, S; Befeler, A; Brown, R; Chung, RT; Curry, MP; Denning, J; Everson, G; Fenkel, JM; Forns, X; Gane, E; Gordon, F; Kuo, A; McHutchison, JG; McNair, L; Moonka, D; O'Leary, J; Saab, S; Schiano, T; Schiff, E; Subramanian, GM; Svarovskaia, E; Symonds, WT; Terrault, NA	1
Arterburn, S; Brainard, D; Brown, RS; Charlton, M; Curry, MP; Denning, J; Dvory-Sobol, H; Fontana, RJ; Forns, X; Gane, E; Gilroy, R; Kirby, B; Kwo, PY; Manns, MP; McHutchison, JG; Muir, AJ; Samuel, D; Symonds, WT; Teperman, L; Terrault, NA	1
Andrade, RJ; Buti, M; Casado, MA; Gros, B; Oyagüez, I; Serra, MA; Turnes, J	1
Aghemo, A; Donato, MF	1
Chang, KC; Chen, CH; Chen, HH; Hu, TH; Huang, CC; Huang, CM; Hung, HC; Lee, CM; Lin, MT; Lu, SN; Tsai, MC; Tseng, PL; Wang, JH; Wu, CK; Wu, YY; Yen, YH	1
Benanti, F; Cacopardo, B; D'Agata, V; Nunnari, G; Pinzone, MR; Rapisarda, L; Spartà, D; Zanghì, AM	1
Andreone, P; Gamal, N; Vitale, G	1
Hisanaga, Y; Ito, T; Kanamori, A; Kiriyama, S; Kitabatake, S; Kumada, T; Tada, T; Tanikawa, M; Toyoda, H	1
Gerlei, Z; Gervain, J; Horváth, G; Hunyady, B; Lengyel, G; Makara, M; Pár, A; Rókusz, L; Szalay, F; Telegdy, L; Tornai, I; Werling, K	1
Hiramatsu, N; Oze, T; Takehara, T	1
Harada, N; Hayashi, N; Hiramatsu, N; Oze, T; Takehara, T; Tatsumi, T	1
Deguchi, H; Ichinose, M; Iguchi, M; Inoue, I; Kato, J; Maeda, Y; Maekita, T; Mori, Y; Moribata, K; Muraki, Y; Nuta, J; Shimizu, R; Shingaki, N; Takifuji, K; Tamai, H; Yamaue, H	1
Faisal, N; Lilly, LB; Marquez, M; Mumtaz, K; Renner, EL	1
Abraldes, JG; Albillos, A; Bañares, R; Bosch, J; Calleja, JL; Forns, X; García-Pagán, JC; García-Retortillo, M; Lens, S; Rincón, D; Sanchez-Tapias, JM	1
Chang, WT; Chen, SC; Chen, YL; Chuang, WL; Dai, CY; Hou, NJ; Huang, CF; Huang, CI; Huang, JF; Lin, PC; Lin, ZY; Tsai, PC; Yeh, ML; Yu, ML	1
Chen, W; Krahn, M	1
Bae, SH; Jang, ES; Jeong, SH; Jung, EU; Kim, IH; Kim, YS; Lee, HC; Lee, SS; Lee, YJ	1
Alexander, PC; James, AM; Long, AG; Shiffman, ML	1
Baba, N; Ikeda, F; Iwasaki, Y; Miyake, Y; Moritou, Y; Nagano, T; Nanba, S; Nouso, K; Ohnishi, H; Seki, H; Senoh, T; Takaguchi, K; Takaki, A; Takeuchi, Y; Yamamoto, K; Yasunaka, T	1
Ahn, SH; Chon, YE; Han, KH; Jung, KS; Kim, BK; Kim, DY; Kim, SU; Lee, HW; Park, JY; Park, YN	1
Badiani, B; Messori, A; Trippoli, S	1
Cai, Z; Dang, S; Deng, H; Guo, Y; Huang, N; Ji, F; Jia, X; Li, Z; Liu, L; Wang, Y; Xue, H; Zhang, S	1
Hatae, T; Hayashi, Y; Imoto, S; Kim, KI; Kim, SK; Kim, SR; Kudo, M; Ohtani, A; Sugimoto, K; Tohyama, M; Yano, Y	1
Chen, TM; Huang, PT; Lin, CC; Wen, CF	1
Serfaty, L	1
Cheng, N; Ford, R; Norvell, JP; Parekh, S; Pillai, AA; Spivey, JR; Wedd, J; Young, N	1
Akuta, N; Arase, Y; Fujiyama, S; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Kunimoto, H; Saitoh, S; Sezaki, H; Sorin, Y; Suzuki, F; Suzuki, Y	1
Antonov, K; Atanasova, E; Boyanova, Y; Jelev, D; Krastev, Z; Mateva, L; Petkova, T; Tomov, B; Zheleva, N	1
Kim, KA	1
Araújo, FS; Coral, GP; Marcon, Pdos S; Mattos, AA; Tovo, CV	1
Johnson, S; Marx, SE; Misurski, D; Parisé, H; Saab, S; Sanchez Gonzalez, Y; Virabhak, S; Wang, A	1
Choi, HS; Chun, HJ; Jung, CH; Kim, TH; Seo, YS; Suh, SJ; Um, SH; Yim, HJ; Yim, SY	1
Gonzalez, YS; Johnson, S; Juday, T; Misurski, D; Parisé, H; Saab, S; Virabhak, S; Wang, A	1
Ceccherini-Silberstein, F; Craxì, A; Perno, CF; Petta, S; Viganò, M	1
Agarwal, K; Brown, A; Cheung, MCM; Foster, GR; Gelson, WTH; Hudson, BE; Irving, WL; MacDonald, DC; McLauchlan, J; Mutimer, DJ; Verma, S; Walker, AJ	1
Choi, JW; Hong, SH; Jang, JW; Kim, DY; Kim, I; Kim, W; Lee, D; Lee, JI; Paik, YH; Yoon, KT	1
Chang, TT; Hsieh, YH; Huang, HT; Hung, TH; Ng, KJ; Tseng, CW; Tseng, KC; Tzeng, SJ; Wu, SF	1
Alric, L; Anty, R; Beaulieux, F; Botta-Fridlund, D; Bouix, C; Canva, V; Carrieri, MP; Conti, F; D'Alteroche, L; Duclos-Vallée, JC; Durand, F; Duvoux, C; Fontaine, H; Lebray, P; Leroy, V; Maynard, M; Métivier, S; Pageaux, GP; Paul, C; Petrov-Sanchez, V; Pradat, P; Roche, B; Roque-Afonso, AM; Samuel, D; Vilotitch, A; Wellems, C	1
Drago, F; Gasparini, G; Marenco, S; Parodi, A; Picciotto, A	1
Bae, SH; Cho, SB; Jang, ES; Jeong, SH; Kim, IH; Kim, YS; Lee, HC; Lee, YJ; Ok, KS	1
Arns, CW; Bastos, JC; Caserta, LC; Miotto, N; Padilla, MA; Vigani, AG	1
Fortune, BE; Lim, JK; McCarty, TR; Njei, B	1
Lanzetta, G; Puoti, C; Scotti, E	1
Akuta, N; Arase, Y; Fujiyama, S; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Saitoh, S; Sezaki, H; Suzuki, F; Suzuki, Y	1
Brooks-Rooney, C; Dan, YY; Eguchi, Y; Kawada, N; Lim, YS; Mondelli, MU; Negro, F; Tanaka, A; Younossi, ZM; Yu, ML	1
Gul, A; Mahmood, S; Saif, T	1
Canbay, A; Gerken, G; Herzer, K; Paul, A; Timm, J; Treckmann, J; Willuweit, K	1
Berardi, S; Bhoori, S; Caraceni, P; Donato, MF; Iemmolo, RM; Invernizzi, F; Lenci, I; Martini, S; Mazzarelli, C; Montalbano, M; Morelli, C; Pieri, G; Romagnoli, R	1
Buti, M; Calleja, JL; Corbett, C; Crespo, J; Diago, M; Fevery, B; Jessner, W; Kalmeijer, R; Kurland, D; Lens, S; Ortega, E; Pascasio, JM; Planas, R; Rodríguez, FG; Romero-Gómez, M	1
Kahn, JG; Lai, JC; Mehta, N; Roberts, JP; Salazar, J; Saxena, V; Volk, M	1
Amano, N; Genda, T; Hirano, K; Ichida, T; Iijima, K; Kanemitsu, Y; Murata, A; Nagahara, A; Narita, Y; Sato, S; Shimada, Y; Tsuzura, H; Wada, R; Watanabe, S	1
Jin, YJ; Lee, JW; Lee, SH; Shin, JY	1
Albillos, A; Ampuero, J; Arenas, J; Bañares, R; Calleja, JL; Crespo, J; Diago, M; Fernandez, I; García-Eliz, M; García-Samaniego, J; Gea, F; Jorquera, F; Lens, S; Llaneras, J; Llerena, S; Mariño, Z; Morillas, RM; Muñoz, R; Navascues, CA; Pascasio, JM; Perelló, C; Rincón, D; Rodriguez, CF; Ruiz-Antorán, B; Sacristán, B; Serra, MA; Simon, MA; Torras, X; Turnes, J	1
Katagiri, S; Tokushige, K; Yamamoto, M	1
Bodenheimer, HC; Joyce, MA; Kadam, JS; Lake-Bakaar, G; Leonard, J; Lin, A	1
Benini, MC; Biagini, MR; Capanni, M; Colagrande, S; Lorefice, E; Milani, S; Salvadori, E; Surrenti, C; Tozzi, A	1
Pár, A; Pár, G	1
Akuta, N; Arase, Y; Hirakawa, M; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Saitoh, S; Sezaki, H; Suzuki, F; Suzuki, Y; Yatsuji, H	2
Fehér, J; Lengyel, G; Wimmer, A	1
Ishikawa, T	1
Boddeker, N; Bondy, S; De Burghgraeve, T; De Clercq, E; Lee, WA; Lehman, LS; Mabery, E; Neyts, J; Oare, D; Paeshuyse, J; Paulson, M; Pürstinger, G; Reiser, H; Shih, IH; Vliegen, I; Zhong, W	1
Chuang, WL; Yu, ML	1
Asjø, B; Myrmel, H; Ulvestad, E	1
Coffin, CS; Terrault, NA	1
Asada, M; Fukunaga, T; Ito, H; Kato, Y; Kawaguchi, K; Kou, T; Kudo, Y; Nakamura, T; Oda, Y; Ohashi, S; Sakuma, Y; Sugiura, Y; Taguchi, N; Watanabe, M; Yamauchi, A; Yazumi, S	1
Floreani, A	1
Bonkovsky, HL; Di Bisceglie, AM; Dienstag, JL; Everson, GT; Ghany, MG; Hoefs, JC; Lee, WM; Lindsay, KL; Lok, AS; Morishima, C; Naishadham, D; Shiffman, ML; Wright, EC	1
Samuel, D	1
Basso, M; Giannini, EG; Picciotto, A; Savarino, V	1
Mallet, V; Pol, S; Vallet-Pichard, A	1
Asselah, T; Bedossa, P; Boyer, N; Cardoso, AC; Carvalho-Filho, RJ; Castelnau, C; Figueiredo-Mendes, C; Giuily, N; Marcellin, P; Martinot-Peignoux, M; Maylin, S; Moucari, R; Ripault, MP; Valla, D	1
Bhoori, S; Germini, A; Lampis, A; Mazzaferro, V; Pellegrinelli, A; Sposito, C; Toffanin, S	1
Hunt, DR; McClune, A; Saab, S; Stone, MA; Tong, MJ	1
Sherman, KE	1
Bonkovsky, HL; De Santo, JL; Di Bisceglie, AM; Dienstag, JL; Ghany, MG; Kim, HY; Lee, WM; Lindsay, KL; Lok, AS; Morgan, TR; Morishima, C; Shiffman, ML; Snow, KK	1
Fehér, J; Lengyel, G	1
Broering, R; Gerken, G; Jiang, M; Kottilil, S; Lu, M; Schlaak, JF; Trippler, M; Zhang, X	1
Furusyo, N; Hayashi, J	1
Fukuhara, T; Gion, T; Ikegami, T; Maehara, Y; Morita, K; Nagata, S; Soejima, Y; Sugimachi, K; Takeishi, K; Taketomi, A; Toshima, T; Umeda, K	1
Chen, SC; Chiu, CF; Chuang, WL; Dai, CY; Hou, NJ; Hsieh, MY; Huang, CF; Huang, CI; Huang, JF; Lin, ZY; Wang, LY; Yang, JF; Yeh, ML; Yu, ML	1
Gonzalez, SA; Keeffe, EB	1
Jahan, S; Khaliq, S; Pervaiz, A	1
Abdo, AA; Almasio, PL; Cacoub, P; Colombo, M; Eslam, M; Esteban, R; Ferenci, P; Hadziyannis, SJ; Harrison, SA; Ibrahim, N; Khattab, MA; Lee, SS; Manns, MP	1
Glória, H; Marinho, R; Nunes, J; Serejo, F; Velosa, J	1
Akuta, N; Arase, Y; Hirakawa, M; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Saitoh, S; Sezaki, H; Suzuki, F; Suzuki, Y	1
Arai, H; Hirokawa, T; Horiuchi, K; Kakizaki, S; Mori, M; Naganuma, A; Ohyama, T; Sato, K; Shimada, Y; Tahara, H; Takagi, H; Tojima, H	1
Masarone, M; Persico, M	1
Crouzet, J; Di Martino, V; Hillon, P; Minello, A; Monnet, E; Thévenot, T	1
Dienstag, JL; Goodman, ZD; Hoefs, JC; Kleiner, DE; Shiffman, ML; Stoddard, AM	1
Arai, M; Fujiwara, K; Imazeki, F; Kanda, T; Maruoka, D; Yokosuka, O	1
Arai, M; Fujiwara, K; Fukai, K; Imazeki, F; Kanda, T; Kato, K; Kimura, M; Mikami, S; Miyauchi, T; Nishino, T; Shimada, N; Sugiura, N; Takada, N; Takashi, M; Tsubota, A; Yokosuka, O; Yonemitsu, Y	1
Chen, CH; Hu, TH; Huang, CM; Hung, CH; Lee, CM; Lu, SN; Wang, JH	1
Hiramatsu, N; Iwasaki, M; Izumi, N; Kakinuma, S; Kurosaki, M; Matsuura, K; Nakagawa, M; Sakamoto, M; Sakamoto, N; Sugauchi, F; Suzuki, Y; Tamori, A	1
Chiba, T; Eso, Y; Henmi, S; Kimura, T; Kita, R; Marusawa, H; Nakajima, J; Nishikawa, H; Osaki, Y; Saito, S; Sakamoto, A; Ueda, Y	1
Branch, AD; Gutierrez, JA; Parikh, N	1
Kudo, M	1
Altamura, S; Crowe, J; Devitt, E; Lawless, MW; Muckenthaler, MU; Mullins, S; Ryan, JD	1
Cipriano, LE; Goldhaber-Fiebert, JD; Holodniy, M; Liu, S; Owens, DK	1
Francque, S; Ho, E; Michielsen, P	1
Bukh, J	1
Buti, M; Deltenre, P; Deuffic-Burban, S; Hatzakis, A; Mathurin, P; Moreno, C; Mühlberger, N; Parkes, J; Rosenberg, W; Siebert, U; Stroffolini, T; Zeuzem, S	1
Chang, KC; Chen, CH; Hu, TH; Hung, CH; Lee, CM; Lin, SC; Lu, SN; Tsai, MC; Tseng, PL; Wang, JH; Yen, MF; Yen, YH	1
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Saitoh, S; Seko, Y; Sezaki, H; Suzuki, F; Suzuki, Y	2
Hagiwara, H; Harada, N; Hayashi, N; Hiramatsu, N; Imai, Y; Inoue, A; Inui, Y; Kanto, T; Kasahara, A; Katayama, K; Kiso, S; Kurokawa, M; Mita, E; Miyagi, T; Miyazaki, M; Oshita, M; Oze, T; Takehara, T; Tamura, S; Tatsumi, T; Yakushijin, T; Yamada, R; Yoshihara, H	1
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kobayashi, T; Kumada, H; Saito, S; Sezaki, H; Suzuki, F; Suzuki, Y	1
Azuma, K; Dohmen, K; Furusyo, N; Hayashi, J; Kajiwara, E; Kotoh, K; Maruyama, T; Nakamuta, M; Nomura, H; Ogawa, E; Satoh, T; Shimoda, S; Takahashi, K; Tanabe, Y	1
Kumada, T; Tada, T; Toyoda, H	1
Furusyo, N; Hayashi, J; Ogawa, E	1
Cresseri, D; Donato, MF; Fabrizi, F; Fogazzi, GB; Martin, P; Messa, P; Passerini, P	1
Chao, YC; Chen, CL; Chen, DS; Chen, PJ; Chuang, WL; Kao, JH; Kuo, HT; Lee, CM; Liao, LY; Lin, CL; Liu, CH; Liu, CJ; Lu, SN; Su, WW; Tung, SY; Wu, SS; Yang, HC; Yang, SS; Yu, ML	1
Ho, HJ; Hsu, YC; Lin, JT; Wu, CY; Wu, MS	1
Deng, H; Ji, F; Li, Z; Zhang, S	1
Karatapanis, S; Lisgos, P; Papastergiou, V; Prodromidou, K; Pselas, C; Stampori, M	1
Perlemuter, G	1
Gervais, A	1
Bronowicki, JP	1
Hilleret, MN; Leroy, V	1
Asselah, T	1
Durand, F	1
Zeuzem, S	1
Malfertheiner, P	1
Gonvers, JJ; Pache, I	1
Färkkilä, M	1
Barbare, JC	1
Duncan, M; Younossi, Z	1
Bacon, BR	1
Omata, M	1
Iwasaki, Y; Shiraha, H; Shiratori, Y	1
Fukuda, A	1
Kondo, Y; Omata, M; Tateishi, R; Yoshida, H	1
Imazeki, F	1
Yamada, G	1
Kobayashi, Y; Matsumoto, E; Sakaguchi, K; Shiratori, Y	1
Accogli, E; Azzaroli, F; Colecchia, A; Derenzini, M; Festi, D; Giovanelli, S; Lodato, F; Mazzella, G; Miracolo, A; Montagnani, M; Mwangemi, C; Nigro, G; Roda, E; Tamé, M; Trere, D	1
Blum, HE; Moradpour, D	1
Hayes, P; Teo, M	1
Liu, C; Shang, X; Terada, N; Zhu, H	1
Armor, JF; Fazili, J; Kamble, R; Kern, W; Kharfan-Dabaja, MA; Toubia, N	1
Karpov, SIu; Krel', PE	1
Adham, M; Baulieux, J; Bizollon, T; Chevallier, M; Ducerf, C; Mabrut, JY; Pradat, P; Radenne, S; Souquet, JC; Trepo, C; Zoulim, F	1
Andreadis, C; Downs, LH; Miller, WT; Schuster, SJ; Svoboda, J; Tsai, DE	1
Jeong, SH; Suh, DJ	1
Changchien, CS; Chen, CL; Chen, WJ; Huang, WS; Hung, CH; Lee, CM; Lu, SN; Tung, HD; Wang, JH	1
Lai, MY	1
Chang, WY; Chuang, WL; Dai, CY; Yu, ML	1
Chen, CH; Hung, CH; Lee, CM; Lu, SN; Tung, HD; Wang, JH	1
Simon, K; Szymczak, A	1
Dieterich, DT; Park, JS; Saraf, N	1
Everson, GT; Sieja, KS	1
Arakawa, Y; Moriyama, M	1
Ruiz-Sancho, A; Soriano, V	1
Adachi, Y; Hayashi, K; Kaito, M; Konishi, M; Watanabe, S; Wu, CH; Wu, GY	1
Carulli, N	1
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Koyama, R; Kumada, H; Saitoh, S; Sezaki, H; Someya, T; Suzuki, F; Suzuki, Y	1
Beckebaum, S; Broelsch, CE; Cicinnati, VR; Gerken, G	1
Franchini, M	1
Chao, PL; Chen, TM; Ho, KS; Huang, PT; Lin, LF; Liu, CC; Siauw, CP; Tsai, MH; Tung, JN	1
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Sezaki, H; Suzuki, F; Suzuki, Y; Yatsuji, H	1
Aida, K; Kurihara, H; Mikami, M; Nagashima, I; Shiga, J; Takikawa, H; Tanaka, A; Uegaki, S	1
Buzatu, E; Cooper, CL; Dudas, J; Esguerra, R; Gorrell, MD; Haber, PS; Hilzenrat, N; Ionescu, C; Leo, MA; Lieber, CS; McCaughan, GW; Neuman, MG; Ramadori, G; Saile, B; Seth, D; Sha, K; Voiculescu, M; Winkler, RE; Wyse, J; Zakhari, S	1
Hansen, BE; Heathcote, EJ; Hofmann, WP; Janssen, HL; Manns, MP; Reichen, J; Schalm, SW; Veldt, BJ; Wedemeyer, H; Zeuzem, S	1
Chuang, WL; Dai, CY; Huang, CF; Huang, JF; Yu, ML	1
Ahn, CS; Choi, KM; Chung, YH; Hwang, S; Kim, KH; Lee, SG; Lee, YS; Moon, DB; Park, JI; Suh, DJ	1
Baldo, V; Baldovin, T; Carderi, I; Floreani, A; Minola, E; Rizzotto, ER	1
Bocsi, J; Jeney, A; Ladányi, A; Lapis, K; Paku, S; Pogány, G; Rśó, E; Tímár, J; Tóvári, J	1
Sherlock, S	1
Cattral, MS; Greig, PD; Hemming, AW; Levy, G; Lilly, LB; Philosophe, B; Superina, RA	1
Sharara, AI	1
Berg, T; Götz, G; Haefker, A; Hopf, U; Neuhaus, P; Neuhaus, R; Schön, MR	1
Chapman, RW; Christie, JM	1
Silvain, C	1
Sterneck, M	1
Kasahara, A	1
Hoofnagle, JH; Howell, C; Jeffers, L	1
Fontaine, H; Pol, S; Vallet-Pichard, A	1
Seeff, LB; Strader, DB	1
Chawla, A; Chung, RT; Contreras, AM; He, W; Saquib, A; Schmidt, EV; Wang, TC; Xavier, RJ	1
Kato, N; Omata, M; Otsuka, M	1
Tanikawa, K	1
Bowlus, CL; Leigh, JP; Leistikow, BN; Schenker, M	1
García-Samaniego, J; Pérez-Olmeda, M; Rodríguez-Rosado, R; Soriano, V	1
Niederau, C	1
Kumada, H	1
Fukuda, Y; Hayashi, K; Nakano, I; Takamatsu, J; Toyoda, H	1

Reviews

80 review(s) available for ribavirin and Liver Neoplasms

Article	Year
S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent. Cells, 2022, 01-25, Volume: 11, Issue:3 Topics: Animals; Antiviral Agents; Betaine; Carcinogenesis; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Colorectal Neoplasms; Humans; Liver Neoplasms; Male; Methionine Adenosyltransferase; Non-alcoholic Fatty Liver Disease; Rats; Ribavirin; S-Adenosylmethionine	2022
Hepatitis C virus/Hepatitis B virus coinfection: Current prospectives. Antiviral therapy, 2023, Volume: 28, Issue:4 Topics: Antiviral Agents; Coinfection; Hepacivirus; Hepatitis B virus; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Ribavirin	2023
Treatment Outcomes of Sofosbuvir/Velpatasvir/Voxilaprevir in Direct-Acting Antiviral-Experienced Hepatitis C Virus Patients: A Systematic Review and Meta-Analysis. Viruses, 2023, 06-30, Volume: 15, Issue:7 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Liver Neoplasms; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Outcome	2023
Impact of etiological treatment on prognosis. Hepatology international, 2018, Volume: 12, Issue:Suppl 1 Topics: Alcohol Abstinence; Antiviral Agents; Carcinoma, Hepatocellular; Combined Modality Therapy; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Hypertension, Portal; Interferon-alpha; Kidney Failure, Chronic; Liver Cirrhosis; Liver Diseases, Alcoholic; Liver Neoplasms; Liver Transplantation; Portal Pressure; Prognosis; Ribavirin	2018
Immunoglobulin G4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review. Transplantation proceedings, 2013, Volume: 45, Issue:2 Topics: Antiviral Agents; Azathioprine; Carcinoma, Hepatocellular; Coinfection; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Immunosuppressive Agents; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Prednisone; Recombinant Proteins; Recurrence; Ribavirin; Time Factors; Treatment Outcome	2013
Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues. Journal of gastroenterology and hepatology, 2014, Volume: 29, Issue:1 Topics: Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Interferon-alpha; Liver Neoplasms; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Virus Activation	2014
[Programs for continuing medical education: a session; 2. Current therapy for chronic hepatitis C]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2014, Mar-10, Volume: 103, Issue:3 Topics: Antiviral Agents; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Education, Medical, Continuing; Genotype; Hepatitis C, Chronic; Heterocyclic Compounds, 3-Ring; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Liver Neoplasms; Oligopeptides; Polyethylene Glycols; Protease Inhibitors; Recombinant Proteins; Ribavirin; Simeprevir; Sulfonamides	2014
[Future perspectives of hepatitis C therapeutics]. [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 2014, Volume: 89, Issue:1 Topics: Antiviral Agents; Drug Discovery; Drug Therapy, Combination; Enzyme Inhibitors; Genome-Wide Association Study; Hepacivirus; Hepatitis C; Humans; Interferons; Interleukins; Liver Neoplasms; Polymorphism, Genetic; Ribavirin; Viral Nonstructural Proteins	2014
ABT-450: a novel agent for the treatment of CHC genotype 1: focus on treatment-experienced patients. Expert review of anti-infective therapy, 2015, Volume: 13, Issue:3 Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclopropanes; Drug Interactions; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Liver Neoplasms; Macrocyclic Compounds; Proline; Protease Inhibitors; Randomized Controlled Trials as Topic; Ribavirin; Ritonavir; RNA, Viral; Sulfonamides; Uracil; Valine	2015
[Hepatitis C: diagnosis, anti-viral therapy, after-care. Hungarian consensus guideline]. Orvosi hetilap, 2015, Mar-01, Volume: 156, Issue:9 Topics: Antiviral Agents; Consensus; Disease Progression; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Hepatitis C; Humans; Hungary; Insurance Coverage; Insurance, Health; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Oligopeptides; Polyethylene Glycols; Proline; Protease Inhibitors; Recombinant Proteins; Registries; Ribavirin; Treatment Outcome	2015
Achieving Sustained Virological Response in Hepatitis C Reduces the Long-Term Risk of Hepatocellular Carcinoma: An Updated Meta-Analysis Employing Relative and Absolute Outcome Measures. Clinical drug investigation, 2015, Volume: 35, Issue:12 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis C; Humans; Liver Neoplasms; Observational Studies as Topic; Outcome Assessment, Health Care; Ribavirin; Risk Factors; Treatment Outcome; Viral Load	2015
Follow-up of patients with chronic hepatitis C and a sustained viral response. Liver international : official journal of the International Association for the Study of the Liver, 2016, Volume: 36 Suppl 1 Topics: Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Comorbidity; Disease Progression; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Ribavirin; Risk Factors; RNA, Viral; Treatment Outcome	2016
[Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? - Indications for Treatment]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2016, Volume: 67, Issue:3 Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Practice Guidelines as Topic; Republic of Korea; Ribavirin	2016
Hepatitis C virus: Promising discoveries and new treatments. World journal of gastroenterology, 2016, Jul-28, Volume: 22, Issue:28 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Protease Inhibitors; Ribavirin; RNA, Viral; Sustained Virologic Response; Viral Load	2016
The impact of hepatitis C virus outside the liver: Evidence from Asia. Liver international : official journal of the International Association for the Study of the Liver, 2017, Volume: 37, Issue:2 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Costs and Cost Analysis; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Japan; Liver Cirrhosis; Liver Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Ribavirin; Sustained Virologic Response; Treatment Failure	2017
Liver transplantation from HCV RNA-positive donors in the era of interferon-free HCV therapeutics: a re-examination of the situation. Minerva gastroenterologica e dietologica, 2017, Volume: 63, Issue:1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Genotype; Hepacivirus; Hepatitis C; Humans; Liver Neoplasms; Liver Transplantation; Recurrence; Ribavirin; RNA, Viral; Sofosbuvir; Tissue Donors; Viral Load	2017
Secondary prevention of recurrence by interferon therapy after ablation therapy for hepatocellular carcinoma in chronic hepatitis C patients. World journal of gastroenterology, 2008, Oct-28, Volume: 14, Issue:40 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Catheter Ablation; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferons; Liver Neoplasms; Neoplasm Recurrence, Local; Ribavirin; Secondary Prevention; Treatment Outcome	2008
Treatment of chronic hepatitis C in Asia: when East meets West. Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:3 Topics: Antiviral Agents; Asia; Asian People; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Male; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Viral Load; White People	2009
The hepatitis C virus enigma. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2009, Volume: 117, Issue:5-6 Topics: Antigens, CD; Antiviral Agents; Biological Evolution; Disease Progression; Drug Synergism; Hepacivirus; Hepatitis C, Chronic; Host-Pathogen Interactions; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Receptors, Virus; Recombinant Proteins; Ribavirin; T-Lymphocyte Subsets; Tetraspanin 28; Viral Hepatitis Vaccines; Viremia; Virus Replication	2009
Management of patients co-infected with HBV and HCV. Expert review of anti-infective therapy, 2009, Volume: 7, Issue:5 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Carrier State; DNA, Viral; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon Type I; Liver Cirrhosis; Liver Neoplasms; Recombinant Proteins; Ribavirin; Risk Factors; RNA, Viral; Superinfection; Treatment Outcome	2009
New trends in hepatitis C management. Presse medicale (Paris, France : 1983), 2010, Volume: 39, Issue:4 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Carriers; Global Health; Hepatitis C, Chronic; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Protease Inhibitors; Recombinant Proteins; Ribavirin	2010
Thymosin alpha 1 for treatment of hepatitis C virus: promise and proof. Annals of the New York Academy of Sciences, 2010, Volume: 1194 Topics: Carcinoma, Hepatocellular; Chronic Disease; Clinical Trials as Topic; Hepacivirus; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Neoplasms; Randomized Controlled Trials as Topic; Ribavirin; Thymalfasin; Thymosin; Treatment Outcome	2010
[Combined interferon, ribavirin treatment and the occurrence of hepatocellular carcinoma]. Orvosi hetilap, 2010, Jul-18, Volume: 151, Issue:29 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Incidence; Interferons; Liver Neoplasms; Ribavirin	2010
[Epidemiological and clinical study for hepatitis C virus infection]. Fukuoka igaku zasshi = Hukuoka acta medica, 2010, Volume: 101, Issue:3 Topics: Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C; HTLV-I Infections; Humans; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Japan; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Ribavirin	2010
Chronic viral hepatitis: epidemiology, molecular biology, and antiviral therapy. Frontiers in bioscience (Landmark edition), 2011, 01-01, Volume: 16, Issue:1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis D, Chronic; Hepatitis Delta Virus; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2011
Sequence variability of HCV Core region: important predictors of HCV induced pathogenesis and viral production. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2011, Volume: 11, Issue:3 Topics: Carcinoma, Hepatocellular; Cell Cycle; Drug Therapy, Combination; Fatty Liver; Genetic Variation; Hepacivirus; Hepatitis C Antigens; Hepatitis C, Chronic; Humans; Insulin Resistance; Interferons; Liver Neoplasms; Ribavirin; Viral Core Proteins; Virus Replication	2011
Management of hepatitis C virus genotype 4: recommendations of an international expert panel. Journal of hepatology, 2011, Volume: 54, Issue:6 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon Type I; Interferons; Interleukins; Liver Neoplasms; Liver Transplantation; Polymorphism, Single Nucleotide; Practice Guidelines as Topic; Recombinant Proteins; Ribavirin	2011
Antiviral therapy: why does it fail in HCV-related chronic hepatitis? Expert review of anti-infective therapy, 2011, Volume: 9, Issue:5 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cryoglobulinemia; Disease Progression; Drug Resistance, Viral; Female; Glomerulonephritis; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Ribavirin; RNA, Viral; Sex Factors; Treatment Outcome; Viral Load	2011
Classical and emerging roles of vitamin D in hepatitis C virus infection. Seminars in liver disease, 2011, Volume: 31, Issue:4 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Liver Neoplasms; Osteoporosis; Ribavirin; Vitamin D; Vitamin D Deficiency; Vitamins	2011
Adjuvant therapy after curative treatment for hepatocellular carcinoma. Oncology, 2011, Volume: 81 Suppl 1 Topics: Antineoplastic Agents; Antiviral Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Clinical Trials as Topic; Hepatitis C; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Meta-Analysis as Topic; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Polyethylene Glycols; Pyridines; Recombinant Proteins; Ribavirin; Sorafenib	2011
Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis C? Minerva gastroenterologica e dietologica, 2012, Volume: 58, Issue:1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Europe; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Japan; Liver Neoplasms; North America; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Risk Assessment; Treatment Outcome; Viral Load	2012
Animal models for the study of hepatitis C virus infection and related liver disease. Gastroenterology, 2012, Volume: 142, Issue:6 Topics: Animals; Antibodies, Neutralizing; Antiviral Agents; Carcinoma, Hepatocellular; Cercopithecidae; Disease Models, Animal; Disease Susceptibility; Hepatitis Antibodies; Hepatitis C; Humans; Immunity, Innate; Interferon-alpha; Liver Diseases; Liver Neoplasms; Mice; Mice, SCID; Pan troglodytes; Platyrrhini; Ribavirin; Virus Replication	2012
Remission of HCV-associated glomerulonephritis with pegylated ifn and ribavirin therapy after liver transplantation: case report and literature review. The International journal of artificial organs, 2013, Volume: 36, Issue:1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Administration Schedule; Drug Therapy, Combination; Glomerulonephritis, Membranous; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon-alpha; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Remission Induction; Ribavirin; Treatment Outcome	2013
[Hepatitis C and alcohol]. Gastroenterologie clinique et biologique, 2002, Volume: 26 Spec No 2 Topics: Alanine Transaminase; Alcoholism; Antiviral Agents; Apoptosis; Biopsy; Carcinoma, Hepatocellular; Clinical Enzyme Tests; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Odds Ratio; Prevalence; Ribavirin; Risk Factors; Time Factors; Viral Load	2002
[Chronic hepatitis C in HIV-HCV coinfected patients]. Gastroenterologie clinique et biologique, 2002, Volume: 26 Spec No 2 Topics: Adult; Age Factors; Amantadine; Antiretroviral Therapy, Highly Active; Antiviral Agents; Carcinoma, Hepatocellular; Child; Clinical Trials as Topic; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Meta-Analysis as Topic; Pilot Projects; Prevalence; Ribavirin; Risk Factors	2002
[Treatment of hepatitis C virus-related cirrhosis]. Gastroenterologie clinique et biologique, 2002, Volume: 26 Spec No 2 Topics: Antiviral Agents; Biopsy; Carcinoma, Hepatocellular; Cohort Studies; Drug Therapy, Combination; Female; Fibrosis; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Meta-Analysis as Topic; Middle Aged; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Ribavirin; Time Factors	2002
[Evaluation of response to treatment in chronic hepatitis C]. Gastroenterologie clinique et biologique, 2002, Volume: 26 Spec No 2 Topics: Alanine Transaminase; Amantadine; Antiviral Agents; Biopsy; Carcinoma, Hepatocellular; Clinical Enzyme Tests; Drug Therapy, Combination; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferons; Liver; Liver Neoplasms; Meta-Analysis as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Ribavirin; Risk Factors; RNA, Viral; Time Factors; Transaminases; Viremia	2002
[Chronic hepatitis C: what to do if the first treatment failed?]. Gastroenterologie clinique et biologique, 2002, Volume: 26 Spec No 2 Topics: Amantadine; Animals; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Ethanol; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Mice; Mice, Transgenic; Multicenter Studies as Topic; Obesity; Randomized Controlled Trials as Topic; Recurrence; Ribavirin; Risk Factors; Smoking; Time Factors	2002
[Hepatitis C and liver transplantation]. Gastroenterologie clinique et biologique, 2002, Volume: 26 Spec No 2 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Clinical Enzyme Tests; Clinical Trials as Topic; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppression Therapy; Interferons; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Pilot Projects; Randomized Controlled Trials as Topic; Recurrence; Ribavirin; Risk Factors; RNA, Viral; Time Factors; Tissue Donors; Transaminases	2002
[Drug therapy of hepatitis B and C]. Duodecim; laaketieteellinen aikakauskirja, 2003, Volume: 119, Issue:6 Topics: Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Reverse Transcriptase Inhibitors; Ribavirin	2003
Treatment options for nonresponders and relapsers to initial therapy for hepatitis C. Cleveland Clinic journal of medicine, 2003, Volume: 70 Suppl 4 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Liver Neoplasms; Recurrence; Retreatment; Ribavirin	2003
Managing hepatitis C. The American journal of managed care, 2004, Volume: 10, Issue:2 Suppl Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Liver Neoplasms; Polyethylene Glycols; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; United States	2004
[Present status of therapy for viral hepatitis in Japan]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 7, Issue:Pt 1 Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Interferons; Japan; Liver Neoplasms; Prognosis; Ribavirin	2004
[Evaluating the efficacy of interferon therapy on hepatitis C patients]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 7, Issue:Pt 1 Topics: Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Drug Therapy, Combination; Fibrosis; Follow-Up Studies; Hepacivirus; Hepatitis C; Humans; Interferons; Liver; Liver Neoplasms; Polymerase Chain Reaction; Ribavirin; RNA, Viral; Treatment Outcome	2004
[Therapeutic effects of interferon on chronic hepatitis C from the aspect of dosage and method of administration]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 7, Issue:Pt 1 Topics: Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Liver Neoplasms; Randomized Controlled Trials as Topic; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome	2004
[Effectiveness of long-acting interferon (peginterferon)]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 7, Issue:Pt 1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Time Factors; Treatment Outcome	2004
[Alternative measures for patients with chronic hepatitis C unresponsive to interferon therapy]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 7, Issue:Pt 1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cysteine; Drug Combinations; Drug Therapy, Combination; Genotype; Glycine; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Iron, Dietary; Liver Neoplasms; Oleanolic Acid; Phlebotomy; Prognosis; Ribavirin; Time Factors	2004
[Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 7, Issue:Pt 1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cysteine; Disease Progression; Drug Combinations; Drug Therapy, Combination; Fibrosis; Glycine; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Liver Neoplasms; Oleanolic Acid; Prognosis; Ribavirin; Risk; Ursodeoxycholic Acid	2004
[Recurrence of hepatocellular carcinoma associated with hepatitis C virus after tumor ablation]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 7, Issue:Pt 1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Catheter Ablation; Combined Modality Therapy; Drug Therapy, Combination; Ethanol; Hepatectomy; Hepatitis C; Humans; Injections, Intralesional; Interferon-alpha; Liver Neoplasms; Neoplasm Recurrence, Local; Prognosis; Ribavirin; Risk Factors; Time Factors	2004
[Hepatitis C]. Therapeutische Umschau. Revue therapeutique, 2004, Volume: 61, Issue:8 Topics: Acute Disease; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Time Factors	2004
Management of hepatitis C. British medical bulletin, 2004, Volume: 70 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepacivirus; Hepatitis C; Humans; Immunotherapy; Interferon-beta; Interferons; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Ribavirin	2004
[Clinical characterization and peculiarities of the clinical course of low-activity hepatitis C]. Klinicheskaia meditsina, 2005, Volume: 83, Issue:1 Topics: Adult; Antiviral Agents; Biopsy; Carcinoma, Hepatocellular; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Prognosis; Recombinant Proteins; Ribavirin	2005
Current status of hepatitis C virus infection in Korea. Intervirology, 2006, Volume: 49, Issue:1-2 Topics: Age Factors; Antiviral Agents; Carcinoma, Hepatocellular; Child; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis B; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Korea; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Prevalence; Ribavirin; Risk Factors; RNA, Viral; Species Specificity	2006
Viral etiology of hepatocellular carcinoma and HCV genotypes in Taiwan. Intervirology, 2006, Volume: 49, Issue:1-2 Topics: Age Factors; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Drug Therapy, Combination; Hepacivirus; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Neoplasms; Multivariate Analysis; Mutation; Ribavirin; RNA, Viral; Species Specificity; Taiwan; Treatment Outcome; Viral Nonstructural Proteins; Viremia	2006
Combined interferon and ribavirin therapy for chronic hepatitis C in Taiwan. Intervirology, 2006, Volume: 49, Issue:1-2 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis C Antibodies; Hepatitis C, Chronic; Hospitals, University; Humans; Incidence; Interferon-alpha; Liver Neoplasms; Male; Ribavirin; Seroepidemiologic Studies; Taiwan	2006
Treatment of chronic hepatitis C in southern Taiwan. Intervirology, 2006, Volume: 49, Issue:1-2 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Species Specificity; Taiwan; Viral Load	2006
[Molecular virology and treatment of patients with chronic hepatitis C]. Przeglad epidemiologiczny, 2005, Volume: 59, Issue:2 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Drug Carriers; Drug Therapy, Combination; Female; Fibrosis; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Failure; Liver Neoplasms; Male; Middle Aged; Poland; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome	2005
HBV plus HCV, HCV plus HIV, HBV plus HIV. Current gastroenterology reports, 2006, Volume: 8, Issue:1 Topics: Algorithms; Antiviral Agents; Carcinoma, Hepatocellular; Chronic Disease; Disease Progression; Drug Interactions; Hepatitis B; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Viral Load	2006
Treatment of interferon-alpha for chronic hepatitis C. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:9 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2006
[HIV and HCV coinfection]. Enfermedades infecciosas y microbiologia clinica, 2006, Volume: 24, Issue:5 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Carcinoma, Hepatocellular; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Contraindications; Disease Progression; Drug Interactions; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Multicenter Studies as Topic; Patient Selection; Polyethylene Glycols; Ribavirin; Risk Factors; Treatment Outcome; Viral Load	2006
[HCV-HBV infection]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64, Issue:7 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Drug Therapy, Combination; Hepatitis B e Antigens; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk	2006
[Recurrent disease after liver transplantation. A therapeutic dilemma or treatable?]. Medizinische Klinik (Munich, Germany : 1983), 2006, Dec-15, Volume: 101, Issue:12 Topics: Age Factors; Antiviral Agents; Carcinoma, Hepatocellular; Cholestasis, Intrahepatic; Disease-Free Survival; Follow-Up Studies; Hepatitis B; Hepatitis C; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Incidence; Interferon-alpha; Liver Diseases; Liver Diseases, Alcoholic; Liver Neoplasms; Liver Transplantation; Middle Aged; Patient Compliance; Prognosis; Recurrence; Ribavirin; Risk Factors; Time Factors	2006
Is time to treat for HCV all the HIV/HCV co-infected hemophiliacs? Hematology (Amsterdam, Netherlands), 2006, Volume: 11, Issue:3 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Carcinoma, Hepatocellular; Case Management; Clinical Trials as Topic; Cohort Studies; Disease Progression; Drug Therapy, Combination; Hemophilia A; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Multicenter Studies as Topic; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin	2006
Inflammation and repair in viral hepatitis C. Digestive diseases and sciences, 2008, Volume: 53, Issue:6 Topics: Alcoholism; Antiviral Agents; Carcinoma, Hepatocellular; Cytokines; Disease Progression; Genotype; Hepatitis C, Chronic; HIV Infections; Humans; Inflammation; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Ribavirin; Risk Factors	2008
Long-term effects of interferon-based therapy for chronic hepatitis C. Oncology, 2007, Volume: 72 Suppl 1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Survival Rate; Treatment Outcome; Viral Load	2007
Antiviral therapy for chronic hepatitis C viral infection. Journal of hepatology, 1995, Volume: 23 Suppl 2 Topics: Antiviral Agents; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Interferon Type I; Liver Cirrhosis; Liver Neoplasms; Patient Selection; Prevalence; Recombinant Proteins; Ribavirin; RNA, Viral	1995
Chronic hepatitis C. Southern medical journal, 1997, Volume: 90, Issue:9 Topics: Antiviral Agents; Blood Transfusion; Carcinoma, Hepatocellular; Cryoglobulinemia; Disease Progression; Forecasting; Genotype; Glomerulonephritis, Membranoproliferative; Hepacivirus; Hepatitis C; Hepatitis, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Porphyria Cutanea Tarda; Ribavirin; Risk Factors; Treatment Outcome	1997
Combination therapy for chronic hepatitis C: interferon and ribavirin. Hospital medicine (London, England : 1998), 1999, Volume: 60, Issue:5 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Recombinant Proteins; Recurrence; Ribavirin	1999
[Antiviral treatment of hepatitis C virus infection]. La Revue de medecine interne, 1999, Volume: 20 Suppl 3 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Protease Inhibitors; Ribavirin; Risk Factors; RNA, Viral; Viral Load	1999
[Etiology of hepatocellular carcinoma. The problem of the primary disease]. Der Internist, 2000, Volume: 41, Issue:2 Pt 2 Topics: Carcinoma, Hepatocellular; Cross-Cultural Comparison; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis, Alcoholic; Liver Neoplasms; Ribavirin; Risk Factors	2000
Treatment strategies for chronic hepatitis C virus infection. Journal of gastroenterology, 2000, Volume: 35, Issue:6 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Carcinoma, Hepatocellular; Drugs, Chinese Herbal; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Interferons; Iron Overload; Liver Neoplasms; Ribavirin; Treatment Outcome; Ursodeoxycholic Acid	2000
Hepatitis C in African Americans: summary of a workshop. Gastroenterology, 2000, Volume: 119, Issue:5 Topics: Antiviral Agents; Black or African American; Carcinoma, Hepatocellular; Hepatitis C, Chronic; Humans; Incidence; Interferons; Liver Neoplasms; Liver Transplantation; Prevalence; Ribavirin; Substance Abuse, Intravenous; United States; Veterans	2000
[Treatments for hepatitis virus C infections]. Gastroenterologie clinique et biologique, 2001, Volume: 25, Issue:3 Topics: Amantadine; Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis C; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Prognosis; Ribavirin	2001
Hepatitis C: a brief clinical overview. ILAR journal, 2001, Volume: 42, Issue:2 Topics: Antiviral Agents; Black People; Carcinoma, Hepatocellular; Disease Progression; Drug Therapy, Combination; Hepatitis C; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Public Health; Remission, Spontaneous; Ribavirin	2001
[Recent progress and prospective view of chronic hepatitis C research]. Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59, Issue:7 Topics: Animals; Carcinoma, Hepatocellular; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Liver Neoplasms; Ribavirin	2001
[Present status of clinical trials on long-acting IFNs preparations (PEG-IFN alpha 2a, alpha 2b, IFN alpha-minipellet)]. Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59, Issue:7 Topics: Carcinoma, Hepatocellular; Clinical Trials as Topic; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome	2001
Management of hepatitis C in HIV-infected persons. Antiviral research, 2001, Volume: 52, Issue:2 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Carcinoma, Hepatocellular; Disease Management; Disease Transmission, Infectious; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Liver Neoplasms; Recurrence; Ribavirin	2001
[Diagnosis and treatment of chronic hepatitis C. Practical recommendations and new developments]. Medizinische Klinik (Munich, Germany : 1983), 2001, Oct-15, Volume: 96, Issue:10 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Contraindications; Cost-Benefit Analysis; Diagnosis, Differential; Genotype; Germany; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Viral Load	2001
[Chronic hepatitis C]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60, Issue:1 Topics: Drug Design; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Liver Neoplasms; Neoplasm Recurrence, Local; Ribavirin	2002
[Impact of HIV on HCV, GBV-C/HGV, and HBV infection]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60, Issue:4 Topics: Anti-HIV Agents; Antibiosis; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Flaviviridae Infections; GB virus C; Hemophilia A; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Viral, Human; HIV Infections; HIV-1; Humans; Interferons; Lamivudine; Liver Neoplasms; Liver Transplantation; Prognosis; Ribavirin	2002

Trials

18 trial(s) available for ribavirin and Liver Neoplasms

Article	Year
Long-term safety and efficacy results in hepatitis C virus genotype 1-infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ-I and TOPAZ-II trials. Journal of viral hepatitis, 2020, Volume: 27, Issue:5 Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carcinoma, Hepatocellular; Cyclopropanes; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Humans; Lactams, Macrocyclic; Liver Neoplasms; Proline; Ribavirin; Ritonavir; Sulfonamides; Sustained Virologic Response; Uracil; Valine	2020
Treatment as Prevention for Hepatitis C (TraP Hep C) - a nationwide elimination programme in Iceland using direct-acting antiviral agents. Journal of internal medicine, 2018, Volume: 283, Issue:5 Topics: Antiviral Agents; Benzimidazoles; Carcinoma, Hepatocellular; Drug Therapy, Combination; Fluorenes; Hepatitis C; Humans; Iceland; Incidence; Liver Cirrhosis; Liver Neoplasms; Mass Screening; Needle-Exchange Programs; Population Surveillance; Ribavirin; Sofosbuvir; Substance Abuse, Intravenous; Uridine Monophosphate	2018
Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study. Gastroenterology, 2015, Volume: 148, Issue:1 Topics: Aged; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Drug Therapy, Combination; Europe; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; New Zealand; Pilot Projects; Recurrence; Ribavirin; RNA, Viral; Sofosbuvir; Time Factors; Treatment Outcome; United States; Uridine Monophosphate; Viral Load; Waiting Lists	2015
Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation. Gastroenterology, 2015, Volume: 148, Issue:1 Topics: Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; New Zealand; Pilot Projects; Prospective Studies; Recurrence; Ribavirin; RNA, Viral; Sofosbuvir; Spain; Time Factors; Treatment Outcome; United States; Uridine Monophosphate; Viral Load	2015
The tertiary prevention of hepatocellular carcinoma in chronic hepatitis C patients. Journal of gastroenterology and hepatology, 2015, Volume: 30, Issue:12 Topics: Aged; Antiviral Agents; Biomarkers, Tumor; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Histocompatibility Antigens Class I; Humans; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Polyethylene Glycols; Predictive Value of Tests; Prospective Studies; Recombinant Proteins; Ribavirin; Tertiary Prevention; Treatment Outcome	2015
Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis C. Journal of clinical pathology, 2016, Volume: 69, Issue:3 Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Deoxyguanosine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon-alpha; Iron Metabolism Disorders; Leukocytes, Mononuclear; Liver; Liver Neoplasms; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Oxidative Stress; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Ribavirin; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome	2016
Simeprevir and Sofosbuvir (SMV-SOF) for 12 Weeks for the Treatment of Chronic Hepatitis C Genotype 1 Infection: A Real World (Transplant) Hepatology Practice Experience. The American journal of gastroenterology, 2016, Volume: 111, Issue:2 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Drug Therapy, Combination; Female; Gastroenterology; Genotype; Graft vs Host Disease; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Logistic Models; Male; Middle Aged; Retrospective Studies; Ribavirin; RNA, Viral; Simeprevir; Sofosbuvir; Treatment Outcome; Viral Load	2016
Simeprevir in combination with sofosbuvir in treatment-naïve and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO). Alimentary pharmacology & therapeutics, 2017, Volume: 45, Issue:3 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Drug Administration Schedule; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Ribavirin; Simeprevir; Sofosbuvir; Sustained Virologic Response; Treatment Outcome	2017
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial. Gastroenterology, 2009, Volume: 137, Issue:6 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Proportional Hazards Models; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors; Treatment Failure; Viral Load	2009
Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:3 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Prognosis; Prospective Studies; Recombinant Proteins; Recurrence; Ribavirin; Risk Factors; Severity of Illness Index; Survival Rate; Treatment Outcome; United States	2010
Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial. Gastroenterology, 2011, Volume: 141, Issue:3 Topics: Adult; Antiviral Agents; Biopsy; Carcinoma, Hepatocellular; Disease Progression; Drug Therapy, Combination; Female; Fibrosis; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Prevalence; Prognosis; Recombinant Proteins; Ribavirin; Time Factors; Treatment Outcome	2011
Occurrence of hepatocellular carcinoma was not a rare event during and immediately after antiviral treatment in Japanese HCV-positive patients. Oncology, 2011, Volume: 80, Issue:5-6 Topics: Adult; Age Factors; Aged; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Japan; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; RNA, Viral; Tomography, X-Ray Computed; Treatment Outcome	2011
Pegylated interferon-α induced hypoferremia is associated with the immediate response to treatment in hepatitis C. Hepatology (Baltimore, Md.), 2012, Volume: 56, Issue:2 Topics: Adult; Aged; Antimicrobial Cationic Peptides; Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cohort Studies; Drug Monitoring; Drug Therapy, Combination; Female; Genotype; Hemochromatosis Protein; Hepatitis C; Hepcidins; Histocompatibility Antigens Class I; Humans; Interferon-alpha; Interferons; Interleukins; Iron; Iron Deficiencies; Liver Neoplasms; Male; Membrane Proteins; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; STAT3 Transcription Factor; Viral Load	2012
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. World journal of gastroenterology, 2004, Nov-01, Volume: 10, Issue:21 Topics: Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Nucleolus Organizer Region; Prospective Studies; Ribavirin; Silver Staining	2004
Antiviral therapy after non-surgical tumor ablation in patients with hepatocellular carcinoma associated with hepatitis C virus. Journal of gastroenterology and hepatology, 2005, Volume: 20, Issue:10 Topics: Aged; Alanine Transaminase; Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Recombinant Proteins; Ribavirin; RNA, Viral; Secondary Prevention; Survival Analysis; Treatment Outcome	2005
Long-term outcome after interferon therapy in elderly patients with chronic hepatitis C. Intervirology, 2007, Volume: 50, Issue:1 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Cause of Death; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Interferon-beta; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Ribavirin; Survival Analysis; Time Factors; Treatment Outcome	2007
Pegylated interferon alpha-2b plus ribavirin for naive patients with HCV-related cirrhosis. Journal of clinical gastroenterology, 2008, Volume: 42, Issue:6 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Logistic Models; Male; Middle Aged; Recombinant Proteins; Recurrence; Ribavirin; Treatment Outcome; Viral Load	2008
Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin. Transplantation proceedings, 1998, Volume: 30, Issue:5 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Middle Aged; Pilot Projects; Polymerase Chain Reaction; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral	1998

Other Studies

176 other study(ies) available for ribavirin and Liver Neoplasms

Article	Year
Direct Relationship between Interleukin-10 Gene Polymorphism and Hepatocellular Carcinoma Complicated by Direct Acting Antiviral Treatment of Hepatitis C Virus. Asian Pacific journal of cancer prevention : APJCP, 2021, Oct-01, Volume: 22, Issue:10 Topics: Adult; Aged; Antiviral Agents; Ascites; Carbamates; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Interleukin-10; Liver Cirrhosis; Liver Neoplasms; Lymphadenitis; Male; Middle Aged; Polymorphism, Single Nucleotide; Pyrrolidines; Ribavirin; Simeprevir; Sofosbuvir; Splenomegaly; Valine	2021
Twenty-year follow-up of an outbreak of hepatitis C in a small rural town of Argentina: The O'Brien Project. Annals of hepatology, 2022, Volume: 27 Suppl 1 Topics: Aged; Antiviral Agents; Argentina; Carcinoma, Hepatocellular; Disease Outbreaks; Drug Therapy, Combination; Follow-Up Studies; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Liver Neoplasms; Ribavirin	2022
Ribavirin inhibits the growth and ascites formation of hepatocellular carcinoma through downregulation of type I CARM1 and type II PRMT5. Toxicology and applied pharmacology, 2022, 01-15, Volume: 435 Topics: Animals; Antimetabolites, Antineoplastic; Ascites; Carcinoma, Hepatocellular; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulation; Epigenesis, Genetic; Eukaryotic Initiation Factor-4E; Humans; Liver Neoplasms; Mice; Protein-Arginine N-Methyltransferases; Ribavirin; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2022
Regression of liver fibrosis and hepatocellular carcinoma development after HCV eradication with oral antiviral agents. Scientific reports, 2022, 01-07, Volume: 12, Issue:1 Topics: Administration, Oral; Aged; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Drug Therapy, Combination; Elasticity Imaging Techniques; Female; Hepatitis C, Chronic; Humans; Imidazoles; Incidence; Interferons; Isoquinolines; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Pyrrolidines; Retrospective Studies; Ribavirin; Seoul; Sulfonamides; Sustained Virologic Response; Time Factors; Treatment Outcome; Valine	2022
Effectiveness of Direct-acting Agents After Liver Transplantation A Real-life Study in Rio de Janeiro. Archives of medical research, 2022, Volume: 53, Issue:6 Topics: Antiviral Agents; Aspartic Acid; Biomarkers; Brazil; Carcinoma, Hepatocellular; Female; Hepacivirus; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Ribavirin; RNA; Transaminases	2022
Before Direct-Acting Antivirals for Hepatitis C Virus: Evaluation of Core Protein R70Q and L/C91M Substitutions in Chronically Infected Brazilian Patients Unresponsive to IFN and/or RBV. Viruses, 2023, 01-09, Volume: 15, Issue:1 Topics: Antiviral Agents; Brazil; Carcinoma, Hepatocellular; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2023
Evolution of liver fibrosis after interferon-based anti-hepatitis C virus therapy failure in 3,049 chronic hepatitis C patients without cirrhosis. Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology, 2023, Volume: 24, Issue:1 Topics: Adult; Antiviral Agents; Female; Fibrosis; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Ribavirin	2023
Immunomodulation of Natural Killer Cell Function by Ribavirin Involves TYK-2 Activation and Subsequent Increased IFN-γ Secretion in the Context of In Vitro Hepatitis E Virus Infection. Cells, 2023, 01-31, Volume: 12, Issue:3 Topics: Carcinoma, Hepatocellular; Hepatitis E; Hepatitis E virus; Humans; Interferon-gamma; Killer Cells, Natural; Liver Neoplasms; Ribavirin	2023
A Retrospective Study of Long-Term Clinical Outcomes in Patients with Chronic Hepatitis C Treated with Interferon and Ribavirin. Discovery medicine, 2023, Volume: 35, Issue:178 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Retrospective Studies; Ribavirin; RNA, Viral; Treatment Outcome	2023
Molecular characterization of hepatitis C virus in liver disease patients in Botswana: a retrospective cross-sectional study. BMC infectious diseases, 2019, Oct-22, Volume: 19, Issue:1 Topics: Adult; Antiviral Agents; Botswana; Carcinoma, Hepatocellular; Cross-Sectional Studies; Drug Resistance, Viral; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Mutation; Phylogeny; Pilot Projects; Retrospective Studies; Ribavirin	2019
New Scoring Method to Predict Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C After Pegylated Interferon and Ribavirin Therapy. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2020, Volume: 40, Issue:2 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Regression Analysis; Retrospective Studies; Ribavirin; Risk Factors	2020
Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose. Gut and liver, 2020, 11-15, Volume: 14, Issue:6 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Republic of Korea; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Outcome	2020
Long-term follow-up of HCV patients with sustained virological response after treatment with pegylated interferon plus ribavirin. Hepatobiliary & pancreatic diseases international : HBPD INT, 2021, Volume: 20, Issue:2 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Follow-Up Studies; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Ribavirin	2021
Hepatocellular carcinoma occurs frequently and early after treatment in HCV genotype 3 infected persons treated with DAA regimens. BMC gastroenterology, 2020, Apr-06, Volume: 20, Issue:1 Topics: Adult; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Interferons; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Pakistan; Polyethylene Glycols; Proportional Hazards Models; Prospective Studies; Pyrrolidines; Ribavirin; Sofosbuvir; Sustained Virologic Response; Time Factors; Tomography, X-Ray Computed; Valine	2020
Real-world safety and effectiveness of retreatment of Egyptian chronic hepatitis C patients not responding to NS5A inhibitor-based therapies. Journal of viral hepatitis, 2020, Volume: 27, Issue:11 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Egypt; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Neoplasms; Prospective Studies; Retreatment; Ribavirin; Sofosbuvir; Treatment Outcome	2020
Long-term clinical benefits of Sofosbuvir-based direct antiviral regimens for patients with chronic hepatitis C in Central and West Africa. Liver international : official journal of the International Association for the Study of the Liver, 2020, Volume: 40, Issue:11 Topics: Africa South of the Sahara; Antiviral Agents; Cote d'Ivoire; Hepatitis C, Chronic; Humans; Liver Neoplasms; Ribavirin; Sofosbuvir	2020
Cost-effectiveness analysis of sofosbuvir and velpatasvir in chronic hepatitis C patients with decompensated cirrhosis. Journal of viral hepatitis, 2021, Volume: 28, Issue:2 Topics: Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Genotype; Hepacivirus; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Infant, Newborn; Liver Cirrhosis; Liver Neoplasms; Ribavirin; Sofosbuvir; Treatment Outcome	2021
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C patients with genotype-2 infection after completed treatment. The Kaohsiung journal of medical sciences, 2021, Volume: 37, Issue:4 Topics: Age Factors; Aged; Antiviral Agents; Benzimidazoles; Carbamates; Carcinoma, Hepatocellular; Drug Combinations; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Imidazoles; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Pyrrolidines; Quinoxalines; Retrospective Studies; Ribavirin; Sofosbuvir; Sulfonamides; Taiwan; Treatment Outcome; Valine	2021
Interleukin-17 haplotyping predicts hepatocellular carcinoma in sofosbuvir, pegylated interferon-alpha-2a & ribavirin treated chronic hepatitis C patients. Virus research, 2021, 01-15, Volume: 292 Topics: alpha-Fetoproteins; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Haplotypes; Hepatitis C, Chronic; Humans; Interferon-alpha; Interleukin-17; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Single Nucleotide; Receptors, Interleukin-17; Recombinant Proteins; Ribavirin; Sofosbuvir	2021
Morbidity and mortality during hepatitis C treatment using sofosbuvir and daclatasvir with or without ribavirin, in a cohort of Egyptian patients. European journal of gastroenterology & hepatology, 2020, Volume: 32, Issue:8 Topics: Antiviral Agents; Carbamates; Child; Drug Therapy, Combination; Egypt; Female; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Imidazoles; Liver Neoplasms; Male; Morbidity; Prospective Studies; Pyrrolidines; Ribavirin; Sofosbuvir; Treatment Outcome; Valine	2020
Occurrence and recurrence of hepatocellular carcinoma in patients with HCV genotype 1b related cirrhosis treated with Ledipasvir + Sofosbuvir ± Ribavirin. Journal of gastrointestinal and liver diseases : JGLD, 2020, 12-13, Volume: 29, Issue:4 Topics: Antiviral Agents; Benzimidazoles; Carcinoma, Hepatocellular; Fluorenes; Hepacivirus; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Neoplasm Recurrence, Local; Retrospective Studies; Ribavirin; Sofosbuvir	2020
Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response. Liver international : official journal of the International Association for the Study of the Liver, 2017, Volume: 37, Issue:10 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Interferons; Italy; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Propensity Score; Proportional Hazards Models; Retrospective Studies; Ribavirin; Risk Factors; Sustained Virologic Response; Time Factors; Treatment Outcome	2017
Long-term follow-up of patients with chronic hepatitis C treated with α-interferon and ribavirin antiviral therapy: clinical and fibrosis impact of treatment response. European journal of gastroenterology & hepatology, 2017, Volume: 29, Issue:7 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Proportional Hazards Models; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Sustained Virologic Response; Time Factors; Treatment Outcome	2017
Relationship of hepatitis B virus infection to the recurrence of hepatocellular carcinoma after direct acting antivirals. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2017, Volume: 36, Issue:3 Topics: Aged; Aged, 80 and over; Antibodies, Viral; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepatitis B Core Antigens; Hepatitis C, Chronic; Humans; Imidazoles; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Pyrrolidines; Retrospective Studies; Ribavirin; Risk Factors; Sofosbuvir; Valine	2017
Noninvasive serum models to predict significant liver related events in chronic hepatitis C. Hepatology international, 2017, Volume: 11, Issue:4 Topics: Adult; Antiviral Agents; Area Under Curve; Carcinoma, Hepatocellular; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Ribavirin	2017
Multiple Endocrine and Neoplastic Diseases After Unsuccessful Treatment of Hepatitis C With Interferon and Ribavirin. The American journal of the medical sciences, 2017, Volume: 354, Issue:1 Topics: Carcinoma, Hepatocellular; Diabetes Mellitus, Type 1; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Polyendocrinopathies, Autoimmune; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thyroid Diseases	2017
The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy. PloS one, 2017, Volume: 12, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Imidazoles; Incidence; Interferon-alpha; Isoquinolines; Kaplan-Meier Estimate; Liver Neoplasms; Middle Aged; Proportional Hazards Models; Pyrrolidines; Ribavirin; Risk Factors; Sulfonamides; Treatment Outcome; Valine; Viral Load; Young Adult	2017
Current treatment status and barriers for patients with chronic HCV infection in mainland China: A national multicenter cross-sectional survey in 56 hospitals. Medicine, 2017, Volume: 96, Issue:34 Topics: Adult; Age Factors; Antiviral Agents; China; Cross-Sectional Studies; Drug Therapy, Combination; Drug Utilization; Fees, Pharmaceutical; Genotype; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Polyethylene Glycols; Ribavirin; Severity of Illness Index; Sex Factors; Socioeconomic Factors; Young Adult	2017
Successful twice interrupted therapy of HCV infection in patients with cirrhosis with hepatocellular carcinoma before and after liver transplantation. BMJ case reports, 2017, Sep-15, Volume: 2017 Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Cyclopropanes; Drug Therapy, Combination; Hepatitis C; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Macrocyclic Compounds; Male; Middle Aged; Proline; Ribavirin; Ritonavir; Sulfonamides; Sustained Virologic Response; Treatment Outcome; Uracil; Valine	2017
The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience. Liver international : official journal of the International Association for the Study of the Liver, 2018, Volume: 38, Issue:4 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Compassionate Use Trials; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Italy; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Prospective Studies; Ribavirin; Sofosbuvir; Waiting Lists	2018
Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2. Digestive diseases (Basel, Switzerland), 2017, Volume: 35, Issue:6 Topics: alpha-Fetoproteins; Antiviral Agents; Biomarkers, Tumor; Bone Morphogenetic Protein 7; Carcinoma, Hepatocellular; Connective Tissue Growth Factor; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Function Tests; Liver Neoplasms; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Outcome	2017
Ribavirin augments doxorubicin's efficacy in human hepatocellular carcinoma through inhibiting doxorubicin-induced eIF4E activation. Journal of biochemical and molecular toxicology, 2018, Volume: 32, Issue:1 Topics: Amino Acid Substitution; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Eukaryotic Initiation Factor-4E; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Mice, Inbred NOD; Mice, SCID; Mutation; Neoplasm Proteins; Phosphorylation; Protein Processing, Post-Translational; Recombinant Proteins; Ribavirin; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays	2018
Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatment. Liver international : official journal of the International Association for the Study of the Liver, 2018, Volume: 38, Issue:6 Topics: Aged; Antiviral Agents; Austria; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Logistic Models; Male; Middle Aged; Ribavirin; Sustained Virologic Response	2018
The association between steatosis and diabetes with hepatocellular carcinoma in non-genotype 3 chronic hepatitis C patients. Liver international : official journal of the International Association for the Study of the Liver, 2018, Volume: 38, Issue:6 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Diabetes Complications; Diabetes Mellitus; Fatty Liver; Female; Genotype; Hepatitis C, Chronic; Humans; Interferons; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Retrospective Studies; Ribavirin; Risk Factors; Sustained Virologic Response; Taiwan	2018
Surgical Outcomes in Hepatitis C Virus-Related Hepatocellular Carcinoma: Special Reference to Sustained Virological Responses to Interferon Therapy. The American surgeon, 2017, Nov-01, Volume: 83, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Hepatocellular; Case-Control Studies; Disease-Free Survival; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Ribavirin; Treatment Outcome	2017
Sorafenib tosylate, Ribavirn and Sofosbuvir combination therapy for HCV virus infected patients with decompensated liver cancer. Pakistan journal of pharmaceutical sciences, 2017, Volume: 30, Issue:6(Suppleme Topics: Adult; Aged; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepatitis C; Humans; Liver Neoplasms; Male; Middle Aged; Ribavirin; Sofosbuvir; Sorafenib; Sustained Virologic Response; Treatment Outcome	2017
Long-term follow-up of ribavirin-free DAA-based treatment in HCV recurrence after orthotopic liver transplantation. Liver international : official journal of the International Association for the Study of the Liver, 2018, Volume: 38, Issue:7 Topics: Aged; Antiviral Agents; Austria; Benzimidazoles; Carbamates; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Fluorenes; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Ribavirin; Simeprevir; Sofosbuvir; Sustained Virologic Response; Valine	2018
Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C without sustained response to combination therapy. Journal of the Formosan Medical Association = Taiwan yi zhi, 2018, Volume: 117, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Platelet Count; Regression Analysis; Retrospective Studies; Ribavirin; Risk Factors; Sustained Virologic Response; Taiwan; Tomography, X-Ray Computed; Treatment Failure	2018
Complete Response of Diffuse Large B Cell Lymphoma After Direct-Acting Antiviral Therapy for Hepatitis C Virus. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:5 Topics: Aged; Antiviral Agents; Carbamates; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Radiography, Abdominal; Ribavirin; Sofosbuvir; Treatment Outcome	2019
Early occurrence and recurrence of hepatocellular carcinoma in hepatitis C virus-infected patients after sustained virological response. Hepatology international, 2018, Volume: 12, Issue:2 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatectomy; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Neoplasms; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic; Ribavirin; Survival Analysis; Sustained Virologic Response	2018
Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus. World journal of gastroenterology, 2018, Apr-07, Volume: 24, Issue:13 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Japan; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Young Adult	2018
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma. Alimentary pharmacology & therapeutics, 2018, Volume: 47, Issue:12 Topics: Aged; Antiviral Agents; Benzimidazoles; Carbamates; Carcinoma, Hepatocellular; Cohort Studies; Drug Therapy, Combination; Female; Fluorenes; Genotype; Hepacivirus; Hepatic Encephalopathy; Hepatitis C, Chronic; Humans; Imidazoles; Interferons; Italy; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Pyrrolidines; Ribavirin; Simeprevir; Sofosbuvir; Sustained Virologic Response; Uridine Monophosphate; Valine	2018
Hepatitis C virus treatment by direct-acting antivirals in successfully treated hepatocellular carcinoma and possible mutual impact. European journal of gastroenterology & hepatology, 2018, Volume: 30, Issue:8 Topics: Aged; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Drug Therapy, Combination; Egypt; Female; Hepatitis C; Humans; Imidazoles; Incidence; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Pyrrolidines; Ribavirin; Risk Factors; Simeprevir; Sofosbuvir; Sustained Virologic Response; Time Factors; Treatment Outcome; Valine	2018
[Clinical value of pegylated interferon-α plus ribavirin-based therapy in antiviral treatment of chronic hepatitis C in China]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2018, Mar-20, Volume: 26, Issue:3 Topics: Antiviral Agents; China; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome	2018
Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real-world experience study. Journal of viral hepatitis, 2018, Volume: 25, Issue:11 Topics: 2-Naphthylamine; Adult; Aged; Anilides; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Cyclopropanes; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver; Liver Cirrhosis; Liver Neoplasms; Macrocyclic Compounds; Male; Middle Aged; Poland; Proline; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; Uracil; Valine; Viral Load	2018
Territory-wide population-based study of chronic hepatitis C infection and implications for hepatitis elimination in Hong Kong. Liver international : official journal of the International Association for the Study of the Liver, 2018, Volume: 38, Issue:11 Topics: Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Hepatocellular; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Hong Kong; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Mortality; Retrospective Studies; Ribavirin; Sustained Virologic Response	2018
Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality. Scientific reports, 2018, 09-12, Volume: 8, Issue:1 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Female; Fibrosis; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Sustained Virologic Response	2018
Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy. Journal of hepatology, 2019, Volume: 70, Issue:1 Topics: Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Hepacivirus; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Japan; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome	2019
Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study. The American journal of gastroenterology, 2019, Volume: 114, Issue:2 Topics: Aged; Antiviral Agents; Benzimidazoles; Breast Neoplasms; Carbamates; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Fluorenes; Head and Neck Neoplasms; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Imidazoles; Interferons; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Neoplasms; Polyethylene Glycols; Prospective Studies; Pyrrolidines; Ribavirin; Simeprevir; Sofosbuvir; Sustained Virologic Response; Valine	2019
Clinical characteristics and prognosis of HCC occurrence after antiviral therapy for HCV patients between sustained and non-sustained responders. Journal of the Formosan Medical Association = Taiwan yi zhi, 2019, Volume: 118, Issue:1 Pt 3 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Ribavirin; Risk Factors; Survival Rate; Sustained Virologic Response; Taiwan	2019
Timely eradication of HCV viremia by PegIFN/RBV is crucial in prevention of post RFA recurrence in CHC-HCC patients. Journal of the Formosan Medical Association = Taiwan yi zhi, 2019, Volume: 118, Issue:8 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Polyethylene Glycols; Proportional Hazards Models; Retrospective Studies; Ribavirin; Secondary Prevention; Sustained Virologic Response; Taiwan; Tertiary Prevention; Viral Load; Viremia	2019
Is there increased risk of hepatocellular carcinoma recurrence in liver transplant patients with direct-acting antiviral therapy? Hepatology international, 2019, Volume: 13, Issue:2 Topics: Aged; Antiviral Agents; Benzimidazoles; Carcinoma, Hepatocellular; Disease-Free Survival; Drug Therapy, Combination; Female; Fluorenes; Hepatitis C, Chronic; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Ribavirin; Simeprevir; Sofosbuvir; Sustained Virologic Response	2019
Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort. Journal of viral hepatitis, 2019, Volume: 26, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Benzimidazoles; Carcinoma, Hepatocellular; Cohort Studies; Drug Therapy, Combination; Female; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Ribavirin; RNA, Viral; Sofosbuvir; Sustained Virologic Response; Uridine Monophosphate	2019
The predictors of sustained virological response with sofosbuvir and ribavirin in patients with chronic hepatitis C genotype 2. The Korean journal of internal medicine, 2021, Volume: 36, Issue:3 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Neoplasm Recurrence, Local; Ribavirin; Sofosbuvir; Treatment Outcome	2021
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver, 2019, Volume: 39, Issue:10 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Coinfection; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Phylogeny; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Failure; Viral Nonstructural Proteins	2019
Recurrence rate of hepatocellular carcinoma in patients with treated hepatocellular carcinoma and hepatitis C virus-associated cirrhosis after ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin therapy. United European gastroenterology journal, 2019, Volume: 7, Issue:5 Topics: 2-Naphthylamine; Aged; Anilides; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cyclopropanes; Hepatectomy; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Liver Neoplasms; Macrocyclic Compounds; Middle Aged; Neoplasm Recurrence, Local; Proline; Prospective Studies; Radiofrequency Ablation; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; Uracil; Valine	2019
Follow-up Results of Anticancer research, 2019, Volume: 39, Issue:7 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Ribavirin; RNA, Viral; Sofosbuvir; Treatment Outcome	2019
Viramidine-Loaded Galactosylated Nanoparticles Induce Hepatic Cancer Cell Apoptosis and Inhibit Angiogenesis. Applied biochemistry and biotechnology, 2020, Volume: 190, Issue:1 Topics: Angiogenesis Inhibitors; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; MCF-7 Cells; Nanoparticles; Neovascularization, Pathologic; Ribavirin	2020
European mitochondrial haplogroups predict liver-related outcomes in patients coinfected with HIV and HCV: a retrospective study. Journal of translational medicine, 2019, 07-26, Volume: 17, Issue:1 Topics: Adult; Antiviral Agents; Biopsy; Carcinoma, Hepatocellular; Coinfection; Disease Progression; DNA, Mitochondrial; Europe; Female; Genotype; Haplotypes; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Liver; Liver Failure; Liver Neoplasms; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Ribavirin; Risk	2019
Interferon alpha and ribavirin collaboratively regulate p38 mitogen-activated protein kinase signaling in hepatoma cells. Cytokine, 2013, Volume: 61, Issue:3 Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Synergism; Hepacivirus; Humans; Interferon-alpha; Liver Neoplasms; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Receptor, Interferon alpha-beta; Ribavirin; RNA, Small Interfering; Transfection	2013
Adenosine kinase is a key determinant for the anti-HCV activity of ribavirin. Hepatology (Baltimore, Md.), 2013, Volume: 58, Issue:4 Topics: Adenosine Kinase; Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Viral; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Liver Neoplasms; Phenotype; Ribavirin; RNA, Viral; Treatment Outcome	2013
Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality. Gut, 2014, Volume: 63, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Hepatocellular; Coinfection; Databases, Factual; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Propensity Score; Recombinant Proteins; Registries; Retrospective Studies; Ribavirin; Survival Analysis; Treatment Outcome; Young Adult	2014
Genetic variation near interleukin 28B and the risk of hepatocellular carcinoma in patients with chronic hepatitis C. Journal of gastroenterology, 2014, Volume: 49, Issue:7 Topics: Adult; Aged; Alanine Transaminase; alpha-Fetoproteins; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Disease Progression; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Genotype; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferon-beta; Interferons; Interleukins; Liver Neoplasms; Male; Middle Aged; Polymorphism, Single Nucleotide; Ribavirin	2014
Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors. World journal of gastroenterology, 2013, Aug-14, Volume: 19, Issue:30 Topics: Adult; Antiviral Agents; Biopsy; Carcinoma, Hepatocellular; Chi-Square Distribution; Disease Progression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Japan; Kaplan-Meier Estimate; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Ribavirin; Risk Assessment; Risk Factors; Time Factors	2013
Did postoperative peg-interferon plus ribavirin really reduce recurrence of hepatitis C virus-related hepatocellular carcinoma? Hepatology (Baltimore, Md.), 2014, Volume: 59, Issue:4 Topics: Carcinoma, Hepatocellular; Female; Hepatitis C; Humans; Interferon-alpha; Liver Neoplasms; Male; Polyethylene Glycols; Ribavirin	2014
Reply: To PMID 23389758. Hepatology (Baltimore, Md.), 2014, Volume: 59, Issue:4 Topics: Carcinoma, Hepatocellular; Female; Hepatitis C; Humans; Interferon-alpha; Liver Neoplasms; Male; Polyethylene Glycols; Ribavirin	2014
Hepatocellular carcinoma after sustained viral response to interferon and ribavirin therapy in cirrhosis secondary to chronic hepatitis C. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2013, Volume: 23, Issue:10 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Incidence; Interferons; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Pakistan; Retrospective Studies; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome	2013
Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C patients on interferon-based anti-viral therapy. Journal of gastroenterology and hepatology, 2014, Volume: 29, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Hepatocellular; Elasticity Imaging Techniques; Female; Forecasting; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Neoplasms; Male; Middle Aged; Predictive Value of Tests; Recombinant Proteins; Ribavirin; Young Adult	2014
Does chemotherapy cause viral relapse in cancer patients with hepatitis C infection successfully treated with antivirals? Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2014, Volume: 12, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Recurrence; Retrospective Studies; Ribavirin	2014
Post-treatment levels of α-fetoprotein predict incidence of hepatocellular carcinoma after interferon therapy. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2014, Volume: 12, Issue:7 Topics: Adult; Aged; alpha-Fetoproteins; Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Japan; Liver Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies; Ribavirin; Risk Factors	2014
Liver transplantation in a child with multifocal hepatocellular carcinoma hepatitis C and management of post-transplant viral recurrence using boceprevir. Pediatric transplantation, 2014, Volume: 18, Issue:2 Topics: Adolescent; Carcinoma, Hepatocellular; Child; Graft Survival; Hepatitis C; Humans; Interferons; Liver Neoplasms; Liver Transplantation; Male; Polyethylene Glycols; Postoperative Complications; Proline; Recurrence; Ribavirin; Severe Combined Immunodeficiency	2014
Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication. Journal of hepatology, 2014, Volume: 61, Issue:1 Topics: Adult; Aged; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Cohort Studies; Female; gamma-Glutamyltransferase; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Ribavirin; Risk Factors; Taiwan	2014
[Diagnosis, treatment, and follow-up of hepatitis C-virus related liver disease. Hungarian national consensus guideline]. Orvosi hetilap, 2014, Volume: 155 Suppl Topics: Algorithms; Antiviral Agents; Comorbidity; Consensus; Drug Administration Schedule; Drug Therapy, Combination; Early Diagnosis; Evidence-Based Medicine; Genotype; Hepacivirus; Hepatitis C; Humans; Hungary; Interferon-alpha; Interferons; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Protease Inhibitors; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome	2014
Increased uptake and new therapies are needed to avert rising hepatitis C-related end stage liver disease in England: modelling the predicted impact of treatment under different scenarios. Journal of hepatology, 2014, Volume: 61, Issue:3 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Cost of Illness; End Stage Liver Disease; England; Health Care Costs; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Models, Statistical; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Treatment Outcome	2014
Effect of peginterferon alfa-2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis C. Journal of gastroenterology and hepatology, 2015, Volume: 30, Issue:2 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Time Factors	2015
Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virological response by pegylated interferon and ribavirin. Digestive diseases and sciences, 2015, Volume: 60, Issue:2 Topics: Adult; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Chi-Square Distribution; Disease Progression; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Neoplasms; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Polyethylene Glycols; Protective Factors; Recombinant Proteins; Republic of Korea; Retrospective Studies; Ribavirin; Risk Factors; RNA, Viral; Time Factors; Treatment Outcome; Viral Load	2015
[Cost-utility analysis of triple therapy with telaprevir in treatment-naïve hepatitis C patients]. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2014, Sep-16, Volume: 38, Issue:5 Topics: Anemia; Antiviral Agents; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Drug Eruptions; Drug Therapy, Combination; Gastrointestinal Diseases; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Markov Chains; Oligopeptides; Polyethylene Glycols; Prevalence; Quality-Adjusted Life Years; Recombinant Proteins; Ribavirin; Severity of Illness Index; Spain	2014
Sofosbuvir treatment in the pre and post liver transplantation phase: the sooner, the better. Gastroenterology, 2015, Volume: 148, Issue:1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepacivirus; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Ribavirin; Sofosbuvir; Uridine Monophosphate	2015
A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2015, Volume: 13, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Hepatocellular; Female; Genetic Predisposition to Disease; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Liver Neoplasms; Male; Middle Aged; Polymorphism, Single Nucleotide; Retrospective Studies; Ribavirin; Risk Factors; Taiwan; Young Adult	2015
Cirrhotic patients are still at risk of developing hepatocellular carcinoma despite Interferon-induced sustained virological response. European review for medical and pharmacological sciences, 2014, Volume: 18, Issue:2 Suppl Topics: Adult; Aged; alpha-Fetoproteins; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Ribavirin; Treatment Outcome	2014
Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection. Journal of gastroenterology and hepatology, 2015, Volume: 30, Issue:7 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Diabetes Complications; Female; Follow-Up Studies; Forecasting; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Time Factors	2015
[Pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C]. Nihon rinsho. Japanese journal of clinical medicine, 2015, Volume: 73, Issue:2 Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Neoplasms; Ribavirin	2015
Efficacy of pegylated interferon and ribavirin combination therapy for patients with hepatitis C virus infection after curative resection or ablation for hepatocellular carcinoma--A retrospective multicenter study. Journal of medical virology, 2015, Volume: 87, Issue:7 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Treatment Outcome; Viral Load	2015
Prognostic effect of response to interferon therapy after laparoscopic splenectomy among patients with marked thrombocytopenia and hepatitis C virus-related cirrhosis. Hepatology international, 2015, Volume: 9, Issue:1 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Disease-Free Survival; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Laparoscopy; Leukocyte Count; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Platelet Count; Polyethylene Glycols; Prognosis; Recombinant Proteins; Ribavirin; RNA, Viral; Splenectomy; Survival Rate; Thrombocytopenia; Viral Load	2015
High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantation. Hepatology international, 2015, Volume: 9, Issue:1 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Postoperative Period; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin; RNA, Viral; Survival Rate	2015
Association Between Severe Portal Hypertension and Risk of Liver Decompensation in Patients With Hepatitis C, Regardless of Response to Antiviral Therapy. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2015, Volume: 13, Issue:10 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepatitis C, Chronic; Humans; Hypertension, Portal; Interferon-alpha; Liver Failure; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Assessment; Spain; Survival Analysis; Treatment Outcome; Viral Load	2015
Disease burden of chronic hepatitis C among immigrants in Canada. Journal of viral hepatitis, 2015, Volume: 22, Issue:12 Topics: Antiviral Agents; Canada; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Drug Therapy, Combination; Emigrants and Immigrants; Health Care Costs; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Neoplasms; Markov Chains; Models, Theoretical; Polyethylene Glycols; Quality-Adjusted Life Years; Retrospective Studies; Ribavirin	2015
Treatment rate and factors related to interferon-based treatment initiation for chronic hepatitis C in South Korea. Journal of medical virology, 2016, Volume: 88, Issue:2 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Hospitals, University; Humans; Interferon-alpha; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Republic of Korea; Ribavirin; Young Adult	2016
Treatment of chronic HCV with sofosbuvir and simeprevir in patients with cirrhosis and contraindications to interferon and/or ribavirin. The American journal of gastroenterology, 2015, Volume: 110, Issue:8 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Contraindications; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Heterocyclic Compounds, 3-Ring; Humans; Hyperbilirubinemia; Intention to Treat Analysis; Interferons; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Ribavirin; RNA, Viral; Sepsis; Simeprevir; Sofosbuvir; Sulfonamides; Time Factors; Uridine Monophosphate	2015
Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response. Gut and liver, 2016, 05-23, Volume: 10, Issue:3 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Elasticity Imaging Techniques; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Pregnancy; Recombinant Proteins; Ribavirin; Risk Factors	2016
[Antiviral treatment and long-term clinical outcome of decompensated cirrhotic patients with hepatitis C virus infection]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2015, Volume: 23, Issue:9 Topics: Alanine Transaminase; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Treatment Outcome	2015
Comparison of Daclatasvir and Asunaprevir for Chronic HCV 1b Infection with Telaprevir and Simeprevir plus Peginterferon and Ribavirin, with a Focus on the Prevention of Occurrence and Recurrence of Hepatocellular Carcinoma. Oncology, 2015, Volume: 89 Suppl 2 Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Interferon alpha-2; Interferon-alpha; Isoquinolines; Japan; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oligopeptides; Polyethylene Glycols; Polymerase Chain Reaction; Prognosis; Pyrrolidines; Recombinant Proteins; Ribavirin; RNA, Viral; Simeprevir; Sulfonamides; Valine; Viral Load	2015
High post-treatment absolute monocyte count predicted hepatocellular carcinoma risk in HCV patients who failed peginterferon/ribavirin therapy. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:6 Topics: Antiviral Agents; Biomarkers, Tumor; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Monocytes; Neoplasm Staging; Polyethylene Glycols; Prognosis; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Time Factors	2016
Long-Term Outcomes of Hepatitis-C-Infected Patients Achieving a Sustained Virological Response and Undergoing Radical Treatment for Hepatocellular Carcinoma. Oncology, 2016, Volume: 90, Issue:3 Topics: Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepatectomy; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Ribavirin; Viral Load	2016
Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma. World journal of gastroenterology, 2016, Feb-28, Volume: 22, Issue:8 Topics: 2-Naphthylamine; Aged; Anilides; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Macrocyclic Compounds; Male; Proline; Ribavirin; Ritonavir; RNA, Viral; Sulfonamides; Treatment Outcome; Uracil; Valine; Viral Load	2016
HEPATOCELLULAR CARCINOMA IN A NON-CIRRHOTIC PATIENT WITH SUSTAINED VIROLOGICAL RESPONSE AFTER HEPATITIS C TREATMENT. Revista do Instituto de Medicina Tropical de Sao Paulo, 2015, Volume: 57, Issue:6 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome	2015
Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the US. Journal of medical economics, 2016, Volume: 19, Issue:8 Topics: 2-Naphthylamine; Adult; Aged; Aged, 80 and over; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Cyclopropanes; Drug Therapy, Combination; Female; Fibrosis; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver Neoplasms; Macrocyclic Compounds; Male; Markov Chains; Middle Aged; Models, Econometric; Proline; Quality-Adjusted Life Years; Ribavirin; Simeprevir; Sofosbuvir; Sulfonamides; Uracil; Valine	2016
Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C. Gut and liver, 2016, Sep-15, Volume: 10, Issue:5 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Republic of Korea; Ribavirin; Sustained Virologic Response; Time	2016
Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States. Advances in therapy, 2016, Volume: 33, Issue:8 Topics: 2-Naphthylamine; Adult; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Cyclopropanes; Disease Progression; Drug Therapy, Combination; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Lactams, Macrocyclic; Liver Cirrhosis; Liver Neoplasms; Macrocyclic Compounds; Markov Chains; Middle Aged; Polyethylene Glycols; Proline; Quality-Adjusted Life Years; Recombinant Proteins; Ribavirin; Ritonavir; Sofosbuvir; Sulfonamides; United States; Uracil; Valine	2016
From current status to optimization of HCV treatment: Recommendations from an expert panel. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2016, Volume: 48, Issue:9 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Coinfection; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Italy; Liver Cirrhosis; Liver Neoplasms; Practice Guidelines as Topic; Ribavirin; Societies, Medical; Viral Load	2016
Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis. Journal of hepatology, 2016, Volume: 65, Issue:4 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; England; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Prospective Studies; Ribavirin; Treatment Outcome	2016
Estimation of direct medical cost related to the management of chronic hepatitis C and its complications in South Korea. Medicine, 2016, Volume: 95, Issue:30 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Female; Health Care Costs; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Republic of Korea; Retrospective Studies; Ribavirin; Sustained Virologic Response; Young Adult	2016
Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin. Clinical interventions in aging, 2016, Volume: 11 Topics: Aged; Antiviral Agents; Aspartate Aminotransferases; Blood Platelets; Carcinoma, Hepatocellular; Disease Progression; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Retrospective Studies; Ribavirin; Risk Factors; Sustained Virologic Response; Taiwan	2016
Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT). Clinics and research in hepatology and gastroenterology, 2017, Volume: 41, Issue:1 Topics: Adolescent; Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; France; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Proline; Quality of Life; Retrospective Studies; Ribavirin; Treatment Outcome	2017
Porphyrin Elevation in a Patient on Treatment With Simeprevir: Could It Be a Possible Explanation for Simeprevir-Associated Photosensitivity? The American journal of gastroenterology, 2016, Volume: 111, Issue:9 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Graft Rejection; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Photosensitivity Disorders; Porphyrins; Recurrence; Ribavirin; Simeprevir; Sofosbuvir	2016
The clinical outcomes of chronic hepatitis C in South Korea: A prospective, multicenter cohort study. Medicine, 2016, Volume: 95, Issue:35 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Republic of Korea; Ribavirin; Risk Factors; Survival Rate; Sustained Virologic Response	2016
Optimal timing for hepatitis C therapy in US patients eligible for liver transplantation: a cost-effectiveness analysis. Alimentary pharmacology & therapeutics, 2016, Volume: 44, Issue:10 Topics: Antiviral Agents; Benzimidazoles; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Disease Progression; Drug Therapy, Combination; Fluorenes; Genotype; Hepacivirus; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Neoplasm Recurrence, Local; Quality-Adjusted Life Years; Ribavirin; Sofosbuvir; United States	2016
Occurrence of hepatocellular carcinoma 13 years after successful antiviral treatment for HCV infection. Journal of gastrointestinal and liver diseases : JGLD, 2016, Volume: 25, Issue:3 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Liver Neoplasms; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Time Factors; Treatment Outcome; Viral Load	2016
Liver Fibrosis and Body Mass Index Predict Hepatocarcinogenesis following Eradication of Hepatitis C Virus RNA by Direct-Acting Antivirals. Oncology, 2016, Volume: 91, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Body Mass Index; Carbamates; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Interferon Type I; Isoquinolines; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Oligopeptides; Pyrrolidines; Ribavirin; Risk Factors; RNA, Viral; Sulfonamides; Sustained Virologic Response; Valine; Young Adult	2016
Regression of hepatocellular carcinoma after treatment with Sofosbuvir - A case report. JPMA. The Journal of the Pakistan Medical Association, 2016, Volume: 66, Issue:11 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Ribavirin; Sofosbuvir; Treatment Outcome	2016
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: a real-life strategy. Liver international : official journal of the International Association for the Study of the Liver, 2017, Volume: 37, Issue:5 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Italy; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Postoperative Period; Preoperative Period; Recurrence; Retrospective Studies; Ribavirin; Sofosbuvir; Sustained Virologic Response	2017
Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma. Transplantation, 2017, Volume: 101, Issue:5 Topics: Antiviral Agents; Benzimidazoles; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Drug Administration Schedule; Drug Therapy, Combination; Fluorenes; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Middle Aged; Models, Economic; Postoperative Care; Preoperative Care; Quality-Adjusted Life Years; Ribavirin; Sofosbuvir; United States; Uridine Monophosphate	2017
Prediction of Hepatocellular Carcinoma Development after Hepatitis C Virus Eradication Using Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein. International journal of molecular sciences, 2016, Dec-20, Volume: 17, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Neoplasms; Male; Membrane Glycoproteins; Middle Aged; Plant Lectins; Polyethylene Glycols; Protein Binding; Receptors, N-Acetylglucosamine; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Young Adult	2016
Assessment of hepatocellular carcinoma risk based on peg-interferon plus ribavirin treatment experience in this new era of highly effective oral antiviral drugs. Medicine, 2017, Volume: 96, Issue:1 Topics: Adult; Age Factors; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Prognosis; Recombinant Proteins; Republic of Korea; Retrospective Studies; Ribavirin; Risk Assessment; Risk Factors	2017
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort. Journal of hepatology, 2017, Volume: 66, Issue:6 Topics: 2-Naphthylamine; Adult; Aged; Aged, 80 and over; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Carcinoma, Hepatocellular; Cohort Studies; Cyclopropanes; Drug Therapy, Combination; Female; Fluorenes; Genotype; Glomerular Filtration Rate; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver Neoplasms; Macrocyclic Compounds; Male; Middle Aged; Neoplasm Recurrence, Local; Proline; Retrospective Studies; Ribavirin; Ritonavir; Sofosbuvir; Spain; Sulfonamides; Sustained Virologic Response; Treatment Outcome; Uracil; Uridine Monophosphate; Valine; Young Adult	2017
[Postoperative interferon therapy after resection of hepatitis C virus-related hepatocellular carcinoma]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2008, Volume: 105, Issue:6 Topics: Aged; Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Drug Therapy, Combination; Female; Hepatectomy; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2008
Concomitant diffuse large B-cell lymphoma and hepatocellular carcinoma in chronic hepatitis C virus liver disease: a study of two cases. Journal of medical virology, 2008, Volume: 80, Issue:8 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepatitis C, Chronic; Humans; Interferons; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Ribavirin; Time Factors	2008
Occurrence of diffuse, poorly differentiated hepatocellular carcinoma during pegylated interferon plus ribavirin combination therapy for chronic hepatitis C. Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:3 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tomography, X-Ray Computed	2008
[The 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), Milan, Italy, April 23-27, 2008]. Orvosi hetilap, 2008, Jul-13, Volume: 149, Issue:28 Topics: Antineoplastic Agents; Antiviral Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Clinical Trials as Topic; Delayed-Action Preparations; Europe; Hepatitis B; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Liver Neoplasms; Niacinamide; Oligopeptides; Patient Compliance; Phenylurea Compounds; Polyethylene Glycols; Proline; Pyridines; Recombinant Proteins; Ribavirin; Societies, Medical; Sorafenib	2008
Hepatocarcinogenesis following HCV RNA eradication by interferon in chronic hepatitis patients. Internal medicine (Tokyo, Japan), 2008, Volume: 47, Issue:19 Topics: Adolescent; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Female; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Ribavirin; Risk Factors; Sex Factors; Young Adult	2008
[Successful elimination of hepatitis C virus after hepatic lobectomy in a patient with hepatocellular carcinoma]. Orvosi hetilap, 2008, Nov-09, Volume: 149, Issue:45 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepacivirus; Hepatectomy; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2008
Substituted imidazopyridines as potent inhibitors of HCV replication. Journal of hepatology, 2009, Volume: 50, Issue:5 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Hepacivirus; Humans; Imidazoles; Interferons; Liver Neoplasms; Protease Inhibitors; Pyridines; Ribavirin; RNA, Viral; Virus Replication	2009
Regression of B-cell lymphoma of the liver with hepatitis C virus infection after treatment with pegylated interferon-alpha and ribavirin. Digestive diseases and sciences, 2010, Volume: 55, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Biopsy; Chemotherapy, Adjuvant; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon-alpha; Liver Neoplasms; Lymphoma, B-Cell; Magnetic Resonance Imaging; Neoplasm Staging; Radiotherapy, Adjuvant; Ribavirin; Treatment Outcome	2010
Hepatitis C: Should antiviral therapy be offered to elderly patients? Nature reviews. Gastroenterology & hepatology, 2009, Volume: 6, Issue:9 Topics: Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Hepatitis C; Humans; Interferons; Life Expectancy; Liver Neoplasms; Middle Aged; Ribavirin; Risk Factors	2009
Focus. Journal of hepatology, 2010, Volume: 52, Issue:1 Topics: Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Drug Delivery Systems; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Humans; Liver Neoplasms; Ribavirin; Treatment Outcome	2010
Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients. Alimentary pharmacology & therapeutics, 2010, Feb-15, Volume: 31, Issue:4 Topics: Adult; Antiviral Agents; Body Mass Index; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Polymerase Chain Reaction; Recurrence; Ribavirin; RNA, Viral; Treatment Outcome	2010
Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis. Journal of hepatology, 2010, Volume: 52, Issue:5 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; RNA, Viral; Treatment Outcome	2010
Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: a proof of principle. Journal of hepatology, 2010, Volume: 52, Issue:5 Topics: alpha-Fetoproteins; Antineoplastic Agents; Antiviral Agents; Benzenesulfonates; beta Catenin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; DNA Mutational Analysis; Everolimus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Point Mutation; Precision Medicine; Pyridines; Ribavirin; Sirolimus; Sorafenib	2010
Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2010, Volume: 16, Issue:6 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cost Savings; Decision Support Techniques; Disease Progression; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Genotype; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Markov Chains; Middle Aged; Patient Selection; Quality-Adjusted Life Years; Recurrence; Ribavirin; RNA, Viral; Severity of Illness Index; Time Factors; Treatment Outcome; Viral Load	2010
The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response. Gut, 2010, Volume: 59, Issue:8 Topics: Animals; Antiviral Agents; Carcinoma, Hepatocellular; Cells, Cultured; Cytokines; Drug Therapy, Combination; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Silencing; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Liver Neoplasms; Mice; Protease Inhibitors; Replicon; Ribavirin; RNA, Small Interfering; Ubiquitins; Viral Load; Virus Replication	2010
Early diagnosis and treatment resolved cholestatic hepatitis C without fibrosis after living donor liver transplantation: report of a case. Surgery today, 2010, Volume: 40, Issue:10 Topics: Antiviral Agents; Biopsy; Cholangiography; Cholestasis, Intrahepatic; Diagnosis, Differential; Drug Carriers; Early Diagnosis; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Middle Aged; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Ribavirin; RNA, Viral; Ultrasonography, Doppler	2010
Diabetes enhances hepatocarcinogenesis in noncirrhotic, interferon-treated hepatitis C patients. The American journal of medicine, 2010, Volume: 123, Issue:10 Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Diabetes Complications; Female; Hepatitis C; Humans; Interferon-alpha; Interferon-beta; Interferons; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Retrospective Studies; Ribavirin; Risk Factors; Time Factors; Young Adult	2010
The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - a multicenter prospective trial. Journal of hepatology, 2011, Volume: 54, Issue:2 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Case-Control Studies; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Logistic Models; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Viral Load	2011
Eradication of hepatitis C virus reduces the risk of hepatocellular carcinoma in patients with compensated cirrhosis. Digestive diseases and sciences, 2011, Volume: 56, Issue:6 Topics: Adult; Aging; Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepacivirus; Hepatitis C; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Ribavirin	2011
Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy. Journal of medical virology, 2011, Volume: 83, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferons; Liver; Liver Neoplasms; Male; Middle Aged; Ribavirin; RNA, Viral; Viral Core Proteins; Young Adult	2011
A retrospective cohort study of partial splenic embolization for antiviral therapy in chronic hepatitis C with thrombocytopenia. Journal of gastroenterology, 2011, Volume: 46, Issue:8 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Combined Modality Therapy; Embolization, Therapeutic; Female; Genotype; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Male; Medication Adherence; Middle Aged; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Splenic Artery; Thrombocytopenia; Treatment Outcome	2011
Long-term outcome of chronic hepatitis C in a population-based cohort and impact of antiviral therapy: a propensity-adjusted analysis. Journal of viral hepatitis, 2011, Volume: 18, Issue:7 Topics: Adolescent; Adult; Aged; Alcohol Drinking; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome	2011
Long-term cohort study of chronic hepatitis C according to interferon efficacy. Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:2 Topics: Adult; Antiviral Agents; Biomarkers; Biopsy; Carcinoma, Hepatocellular; Cause of Death; Chi-Square Distribution; Combined Modality Therapy; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Japan; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Ribavirin; Risk Assessment; Risk Factors; RNA, Viral; Time Factors; Treatment Outcome; Viral Load	2012
Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients. Antiviral therapy, 2011, Volume: 16, Issue:7 Topics: Adult; Aged; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis B; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Ribavirin; Risk Factors; Treatment Outcome	2011
Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis C. Journal of hepatology, 2012, Volume: 56, Issue:3 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Data Mining; Decision Trees; Female; Hepatitis C, Chronic; Humans; Interferons; Liver Neoplasms; Male; Middle Aged; Models, Statistical; Polyethylene Glycols; Ribavirin; Risk Assessment; Risk Factors	2012
Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study. Journal of gastroenterology, 2012, Volume: 47, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Incidence; Interferons; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Ribavirin; Risk Factors; Treatment Outcome; Young Adult	2012
New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis. Annals of internal medicine, 2012, Feb-21, Volume: 156, Issue:4 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Decision Support Techniques; Disease Progression; Drug Therapy, Combination; Female; Genotype; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Liver Cirrhosis; Liver Neoplasms; Male; Markov Chains; Medication Adherence; Protease Inhibitors; Quality-Adjusted Life Years; Ribavirin; Risk Factors; Treatment Outcome	2012
Predicted effects of treatment for HCV infection vary among European countries. Gastroenterology, 2012, Volume: 143, Issue:4 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Drug Therapy, Combination; Europe; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Male; Markov Chains; Mass Screening; Middle Aged; Polyethylene Glycols; Protease Inhibitors; Ribavirin	2012
A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:11 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Decision Support Techniques; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferons; Liver Neoplasms; Prognosis; Ribavirin; Treatment Outcome	2012
Amino acid substitutions in the hepatitis C Virus core region and lipid metabolism are associated with hepatocarcinogenesis in nonresponders to interferon plus ribavirin combination therapy. Intervirology, 2013, Volume: 56, Issue:1 Topics: Amino Acid Substitution; Antiviral Agents; Carcinoma, Hepatocellular; Cholesterol, HDL; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Humans; Interferons; Liver Neoplasms; Ribavirin; Risk Factors; Viral Core Proteins; Viral Load	2013
Incidence of hepatocellular carcinoma in HCV-infected patients with normal alanine aminotransferase levels categorized by Japanese treatment guidelines. Journal of gastroenterology, 2013, Volume: 48, Issue:4 Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Clinical Enzyme Tests; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Japan; Liver Neoplasms; Male; Middle Aged; Patient Selection; Platelet Count; Polyethylene Glycols; Practice Guidelines as Topic; Recombinant Proteins; Retrospective Studies; Ribavirin; Severity of Illness Index; Treatment Outcome	2013
Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C. Hepatology (Baltimore, Md.), 2013, Volume: 57, Issue:3 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Incidence; Interferons; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Ribavirin; Risk Factors	2013
Efficacy and anticarcinogenic activity of ribavirin combination therapy for hepatitis C virus-related compensated cirrhosis. Intervirology, 2013, Volume: 56, Issue:1 Topics: Adult; Aged; Anticarcinogenic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Ribavirin; Risk Factors	2013
Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: a prospective, multicenter study. Journal of hepatology, 2013, Volume: 58, Issue:3 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Logistic Models; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin	2013
Lower incidence of hepatocellular carcinoma in patients with transient virologic response to peginterferon and ribavirin combination therapy: is it really the effect of the therapy? Journal of hepatology, 2013, Volume: 58, Issue:4 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Neoplasms; Male; Polyethylene Glycols; Ribavirin	2013
Reply to: "Lower incidence of hepatocellular carcinoma in patients with transient virologic response to peginterferon and ribavirin combination therapy: is it really the effect of the therapy?". Journal of hepatology, 2013, Volume: 58, Issue:4 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Neoplasms; Male; Polyethylene Glycols; Ribavirin	2013
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up. Hepatology (Baltimore, Md.), 2013, Volume: 57, Issue:6 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Coinfection; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Mutation; Polyethylene Glycols; Promoter Regions, Genetic; Recombinant Proteins; Recurrence; Ribavirin; Treatment Outcome; Viral Core Proteins	2013
Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma. Hepatology (Baltimore, Md.), 2013, Volume: 58, Issue:1 Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Cohort Studies; Female; Hepatitis C; Humans; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Postoperative Period; Proportional Hazards Models; Recombinant Proteins; Recurrence; Ribavirin; Taiwan	2013
Efficacy of interferon-based antiviral therapy on the risk of hepatocellular carcinoma of patients with chronic hepatitis C: further evidence in decompensation cirrhosis. Journal of hepatology, 2013, Volume: 58, Issue:6 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Neoplasms; Male; Polyethylene Glycols; Ribavirin	2013
Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C: a prospective study. European journal of gastroenterology & hepatology, 2013, Volume: 25, Issue:7 Topics: Adult; Antiviral Agents; Aspartate Aminotransferases; Biomarkers; Carcinoma, Hepatocellular; Chi-Square Distribution; Disease Progression; Drug Therapy, Combination; Female; Greece; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Platelet Count; Polyethylene Glycols; Predictive Value of Tests; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors; RNA, Viral; Time Factors; Treatment Outcome; Viral Load	2013
[Chronic hepatitis C virus infection: always treat!--Pro]. Deutsche medizinische Wochenschrift (1946), 2002, Sep-06, Volume: 127, Issue:36 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Ribavirin	2002
[What therapy is meaningful in chronic hepatitis C and resection of hepatocellular carcinoma for recurrence prophylaxis?]. Deutsche medizinische Wochenschrift (1946), 2002, Nov-29, Volume: 127, Issue:48 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Recurrence; Ribavirin	2002
[Hepatitis C]. Revue medicale de la Suisse romande, 2002, Volume: 122, Issue:10 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Diagnosis, Differential; Hepatitis C; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Prognosis; Recombinant Proteins; Ribavirin; Risk Factors	2002
[A small-sized hepatocellular carcinoma]. Gastroenterologie clinique et biologique, 2003, Volume: 27, Issue:5 Suppl Topics: Antineoplastic Agents; Antiviral Agents; Biopsy, Needle; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Diagnosis, Differential; Fatal Outcome; Hepatitis C; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Patient Selection; Ribavirin; Tomography, X-Ray Computed; Ultrasonography, Interventional	2003
STAT3 induces anti-hepatitis C viral activity in liver cells. Biochemical and biophysical research communications, 2004, Nov-12, Volume: 324, Issue:2 Topics: Antiviral Agents; Blotting, Northern; Blotting, Western; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cytokines; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Genes, Dominant; Hepacivirus; Humans; Inflammation; Interferons; Interleukin-6; Ligands; Liver; Liver Neoplasms; Luciferases; Plasmids; Protein Structure, Tertiary; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA; RNA, Messenger; STAT3 Transcription Factor; Time Factors; Trans-Activators; Transfection; Tyrphostins	2004
Remission of natural-killer cell lymphoma of the liver with anti-hepatitis C therapy. American journal of hematology, 2005, Volume: 78, Issue:3 Topics: Antiviral Agents; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Killer Cells, Natural; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recombinant Proteins; Remission Induction; Ribavirin; Tumor Virus Infections	2005
Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005, Volume: 5, Issue:8 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Graft Survival; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recurrence; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load	2005
Regression of advanced non-splenic marginal zone lymphoma after treatment of hepatitis C virus infection. Leukemia & lymphoma, 2005, Volume: 46, Issue:9 Topics: Drug Therapy, Combination; Hepatitis C; Humans; Interferons; Liver Neoplasms; Lymphatic Metastasis; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Ribavirin; Salivary Gland Neoplasms	2005
De novo hepatocellular carcinoma in a patient with chronic hepatitis C 5 years after sustained virologic response to interferon/ribavirin therapy. Digestive diseases and sciences, 2006, Volume: 51, Issue:3 Topics: Antiviral Agents; Biopsy, Needle; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Drug Therapy, Combination; Follow-Up Studies; Hepatectomy; Hepatitis C, Chronic; Humans; Immunohistochemistry; Interferons; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Ribavirin; Risk Assessment; Severity of Illness Index	2006
siRNA-resistance in treated HCV replicon cells is correlated with the development of specific HCV mutations. Journal of viral hepatitis, 2006, Volume: 13, Issue:11 Topics: Base Sequence; Carcinoma, Hepatocellular; Cell Line, Tumor; Hepacivirus; Humans; Liver Neoplasms; Microscopy, Fluorescence; Molecular Sequence Data; Point Mutation; Replicon; Ribavirin; RNA Interference; RNA, Messenger; RNA, Small Interfering; RNA, Viral; Transfection; Viral Nonstructural Proteins	2006
The faster the better? Internal and emergency medicine, 2006, Volume: 1, Issue:2 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Forecasting; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Liver Cirrhosis; Liver Neoplasms; Male; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Viral Load	2006
Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy. Journal of gastroenterology and hepatology, 2007, Volume: 22, Issue:5 Topics: Adult; Age Factors; Aged; alpha-Fetoproteins; Antiviral Agents; Aspartate Aminotransferases; Biomarkers; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Logistic Models; Male; Middle Aged; Odds Ratio; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; RNA, Viral; Severity of Illness Index; Time Factors; Treatment Outcome; Up-Regulation; Viral Load	2007
Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis C. Journal of medical virology, 2007, Volume: 79, Issue:8 Topics: Aged; Antiviral Agents; Drug Administration Schedule; Hepatitis C, Chronic; Humans; Interferons; Liver Neoplasms; Middle Aged; Ribavirin; Risk Factors	2007
Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C. World journal of gastroenterology, 2007, Oct-21, Volume: 13, Issue:39 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Fatty Liver; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Humans; Interferons; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Ribavirin; Risk Factors; RNA, Viral	2007
Summaries for patients. Sustained virologic response in hepatitis C. Annals of internal medicine, 2007, Nov-20, Volume: 147, Issue:10 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recombinant Proteins; Retrospective Studies; Ribavirin; RNA, Viral; Treatment Outcome	2007
Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Annals of internal medicine, 2007, Nov-20, Volume: 147, Issue:10 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recombinant Proteins; Retrospective Studies; Ribavirin; RNA, Viral; Treatment Outcome	2007
[Clinical outcome after living donor liver transplantation in patients with hepatitis C virus-associated cirrhosis]. The Korean journal of hepatology, 2007, Volume: 13, Issue:4 Topics: Adult; Aged; Antiviral Agents; Combined Modality Therapy; Female; Graft Survival; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin; Severity of Illness Index; Treatment Outcome	2007
The antimetabolite Tiazofurin (TR) inhibits glycoconjugate biosynthesis and invasiveness of tumour cells. European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:1 Topics: Amino Acid Sequence; Animals; Antimetabolites, Antineoplastic; Cell Adhesion; Cell Movement; Dose-Response Relationship, Drug; Flow Cytometry; Glycoconjugates; Humans; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Neoplasm Invasiveness; Neoplasm Transplantation; Neoplasms; Ribavirin; Tumor Cells, Cultured	1996
The University of Toronto liver transplant program. Clinical transplants, 1996 Topics: Adult; Alprostadil; Antiviral Agents; Child; Graft Survival; Hepatitis B; Hepatitis C; Hospitals, University; Humans; Immunization, Passive; Immunoglobulins; Immunosuppression Therapy; Lamivudine; Liver Neoplasms; Liver Transplantation; Ontario; Patient Selection; Recurrence; Retrospective Studies; Ribavirin; Survival Rate; Transplantation, Heterologous	1996
Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system. Proceedings of the National Academy of Sciences of the United States of America, 2001, Aug-14, Volume: 98, Issue:17 Topics: Amantadine; Animals; Antiviral Agents; Bacteriophage T7; Carcinoma, Hepatocellular; Chlorocebus aethiops; DNA, Complementary; Gene Expression Regulation, Viral; Genes, Synthetic; Hepacivirus; Humans; Interferon-alpha; Liver Neoplasms; Oligodeoxyribonucleotides, Antisense; Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Catalytic; RNA, Viral; Terminator Regions, Genetic; Transfection; Tumor Cells, Cultured; Viral Proteins; Virus Replication	2001
Costs of hepatitis C. Archives of internal medicine, 2001, Oct-08, Volume: 161, Issue:18 Topics: Adult; Aged; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Costs and Cost Analysis; Cross-Sectional Studies; Female; Health Expenditures; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recombinant Proteins; Ribavirin; Survival Rate; United States	2001